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ABSTRACT 
 
Shakya, Sapana. Screening for Melanoma for At-Risk Population: A Practice Guide. 
Unpublished Doctor of Nursing Practice scholarly project, University of 
Northern Colorado, 2019. 
 
 
 Melanoma is a lethal skin cancer that kills one American every hour 
(American Academy of Dermatology, 2018b).  The incidence and prevalence rate of 
melanoma is on the rise and continues to affect people, increasing the mortality and 
morbidity rate and financial burden of the disease.  
 In 2016, the U.S. Preventive Services Task Force concluded that there was 
insufficient evidence to assess the balance of benefits and harms of visual skin 
examination by a clinician to screen for skin cancer in adults.  However, this 
recommendation was only applicable to the patients who were asymptomatic.  The 
routine skin cancer screening has shown promising results in patients who are at high 
risk for melanoma (American Cancer Society, 2018b).  Primary care providers do not 
perform routine skin cancer screenings for melanoma or do not even perform 
screening to identify if the patients are at high risk for melanoma or not.  Thus there is 
a lack of a standardized screening tools/models and workflow processes to include 
melanoma screening in the clinic settings.  
 To address this need, an evidence-based melanoma screening workflow 
algorithm was developed specifically to a federally qualified health center in a rural 
and small mountain community in Northern Colorado.  The workflow algorithm 
included the self-assessment of melanoma risk score (SAMScore) as the risk 
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prediction model to screen patients at high risk for melanoma.  The Doctor of Nursing 
Practice (DNP) scholarly project was implemented to screen patients for melanoma 
between ages 35 to 75 years old for annual exams, excluding well women visits, who 
were able to speak, read, and write in English.  Depending on the screening result, an 
appropriate intervention was done by the providers of the clinic by performing a full-
body skin exam or biopsy or referral or educating patients on primary prevention of 
melanoma.  The project was evaluated by utilizing the Donabedian framework.  
 After implementation, there was a 300% increase in the number of melanoma 
screenings completed, increased awareness on melanoma, and melanoma screening 
protocols among the providers and patients.  The clinic has continued to utilize the 
melanoma screening algorithm and SAMScore to screen patients for melanoma and 
continues to distribute the handout on primary prevention of melanoma by the 
American Association of Dermatology.  Further studies are needed to assess the 
validity of the SAMScore in languages other than English and French and evaluate the 
effectiveness of the SAMScore and the melanoma screening algorithm in a larger 
clinic with a greater number of staff.  
Keywords: melanoma screening, melanoma guideline, melanoma algorithm, 
skin cancer  
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CHAPTER I 
 
INTRODUCTION 
 
Background 
Melanoma is defined as “the cancerous growth of the skin cells due to 
unrepaired deoxyribonucleic acid damage that causes cells to multiply rapidly and 
form malignant tumors” (Skin Cancer Foundation, 2019, p. 1).  It is highly aggressive 
and metastatic.  Metastatic melanoma is a fatal disease with rapid systemic 
dissemination (Tas, 2012).   
Skin is the largest organ of the body and consists of two main layers, the 
epidermis and the dermis (National Cancer Institute, 2019).  The outer layer of the 
skin, the epidermis, consists of three cell types: squamous, basal, and melanocytes 
(National Cancer Institute, 2019).  Squamous cells are the thin flat cells forming the 
top of the epidermis (National Cancer Institute, 2019).  Basal cells are round cells 
located underneath the squamous cells (National Cancer Institute, 2019).  Melanocytes 
are located under basal cells and produce a pigment called melanin that gives skin its 
color (National Cancer Institute, 2019).  The uncontrolled proliferation of melanocytes 
is called melanoma.  It is one of the most aggressive forms of skin cancer and can 
metastasize to other parts of the body via the lymphatic system and bloodstream 
(Dinnes et al., 2018).  The most common target sites for metastasis for melanoma 
include the liver, bone, and brain (Tas, 2012).  Approximately 4% of newly diagnosed 
melanoma patients will have the disease metastasized to other parts of the body at the 
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time of diagnosis (Tas, 2012).  With any metastatic disease, including metastatic 
melanoma, the median survival time is about 12 months (Tas, 2012).  Basal and 
squamous cells can proliferate in an uncontrolled manner and become basal cell 
carcinoma and squamous cell carcinoma.  However, these malignancies are not as 
aggressive as melanoma and rarely metastasize to other organs or parts of the body 
(National Cancer Institute, 2019). 
Risk Factors of Melanoma 
Early diagnosis is the principal factor that can improve the prognosis of 
melanoma.  Early diagnosis refers to catching the localized melanoma before it 
metastasizes to other organs or parts of the human body.  The five-year survival rate 
for the localized melanoma is about 98% compared to regional melanoma of 64% and 
distant melanoma metastasis of 23% (American Cancer Society, 2019b).  The etiology 
of melanoma is complex and heterogeneous.  The risk of developing melanoma 
depends on both environmental and genetic factors (Craythome & Al-Niami, 2017).  
Prolonged exposure to ultraviolet radiation is the greatest risk factor for melanoma 
(Watson, Holman, & Maguire-Eisen, 2016).  The ultraviolet radiation causes 
deoxyribonucleic acid damage through the formation of pyrimidine dimers, 
photoproducts, gene mutations, oxidative stress, inflammation, and 
immunosuppression (Potrony et al., 2015).  A study was conducted on the joint effects 
of sun exposure during childhood and adulthood on melanoma risk (Oliveria, Geller, 
Heneghan, & Jorgensen, 2006).  The odds ratio of having melanoma in adults with 
intense childhood and adulthood sun exposure was 4.5% compared to 2% of 
low/moderate childhood and adulthood sun exposure (Oliveria et al., 2006).  
Occupational exposure and intense exposure to ultraviolet radiation such as indoor 
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tanning are also highly associated with melanoma (Watson et al., 2016).  Indoor 
tanning before the age of 35 years increases the risk of melanoma by 59% and the risk 
increases with each use (American Academy of Dermatology, 2018a).  Only one 
indoor tanning session can increase the risk of melanoma by 20% (American 
Academy of Dermatology, 2018a).   
Furthermore, genetic factors also strongly influence the risk of melanoma.  
Melanocyte produces a pigment called melanin that gives color to skin and eyes.  The 
melanin absorbs and scatters the energy from ultraviolet light protecting the epidermal 
cells from damage (Watson et al., 2016).  Thus the amount of melanin or the degree of 
pigmentation is inversely related to sun sensitivity and skin cancer risk (Watson et al., 
2016).  Some of the characteristics that increase the risk of melanoma include 
naturally fair skin tone or skin type of Fitzpatrick I; light color eyes; blonde or red 
hair; dysplastic nevi or common moles (more than 50 moles); and sensitive skin that 
burns, freckles, reddens, or becomes painful after sun exposure (Watson et al., 2016).  
In addition, the personal and family history of melanoma increases the risk of 
melanoma (Watson et al., 2016).   
According to the Aim at Melanoma Foundation (2014a), at least 5% of people 
with a past history of melanoma will develop a new melanoma, putting them at 
increased risk for melanoma.  The risk of melanoma multiplies by 30 to 70 times with 
multiple first-degree family members (Aim at Melanoma Foundation, 2014a).  The 
Skin Cancer Foundation (2019) stated that a person with a first-degree relative 
diagnosed with melanoma is 50 times more likely to develop the disease compared to 
a person without a family history of melanoma.  Immunosuppressed individuals who 
do not have the ability to right infections or at risk for infection are also at an 
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increased risk for melanoma.  Melanoma high-risk genes are genes that put an 
individual at high risk for developing melanoma.  The two genes that are associated 
with melanoma susceptibility are cyclin-dependent kinase inhibitor 2A and cyclin-
dependent kinase 4 (Potrony et al., 2015).  Also, genetic syndromes are responsible for 
the development of melanomas such as familial atypical mole melanoma syndrome 
and xeroderma pigmentosum (Watson et al., 2016).  
Statistical Significance 
of Melanoma in the 
United States 
Melanoma is the deadliest type of skin cancer, ranking it as the fifth and the 
seventh most common cancer among males and females in the United States, 
respectively (Jiang et al., 2017).  The incidence of melanoma is rising rapidly and is 
expected to double by 2030 (Robinson et al., 2018).  The Centers for Disease Control 
and Prevention (2015) stated that the incidence rate of melanoma has increased from 
11.2 per 100,000 in 1982 to 22.7 per 100,000 in 2011.  The incidence rate of 
melanoma is higher in women compared to men before the age of 50 (American 
Academy of Dermatology, 2018b).  It is the second most common cancer in females 
between ages 15 to 29 years, and the incidence rate of melanoma increased up by 
800% in women ages 18 to 39 years from 1970 to 2009 (American Academy of 
Dermatology, 2018b).  The risk of melanoma increases with age among men.  The rate 
is twice as high in men by age 65 years and three times as high in men by age 80 years 
(American Academy of Dermatology, 2018b).  The annual incidence rate of 
melanoma in non-Hispanic Caucasians is 26 per 100,000 compared to 4 per 100,000 in 
Hispanics and 1 per 100,000 in African Americans (American Academy of 
Dermatology, 2018b).  It has been estimated that melanoma will affect one in 27 men 
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and one in 40 women in their lifetime (American Academy of Dermatology, 2018b).  
According to the American Cancer Society (2019a), the lifetime risk of getting 
melanoma is 2.6% (one in 38) for Whites, 0.1% (one in 1,000) for Blacks, and 0.58% 
(one in 172) for Hispanics.  The median age of diagnosis of melanoma is 63 years, and 
the median age of death related to melanoma is 69 years (U.S. Preventive Services 
Task Force, 2016).  Johnson et al. (2017) recommended the screening age of 
melanoma as 35 to 75 years compared with the U.S. Preventive Services Task Force 
cancer recommendations for colorectal, cervical, breast, and lung cancer.   
The mortality rate of melanoma is on the rise.  According to the American 
Academy of Dermatology (2018b), melanoma kills one American every hour.  In 
2012, 55,488 deaths were attributed to malignant melanoma globally (Johansson, 
Brodersen, Gotzsche, & Jorgensen, 2016).  Even though melanoma accounts for 1% of 
skin cancers, it is responsible for most skin cancer-related deaths in the United States 
(Caple & Holle, 2018).  Approximately 4.9 million adults were treated for skin cancer 
between 2007 and 2011, with a treatment cost of $8.1 billion in the United States 
(American Academy of Dermatology, 2018b).  The annual treatment cost for 
melanoma is estimated to be $3.3 billion (American Academy of Dermatology, 
2018b).  
Statistical Significance of 
Melanoma in Colorado 
 According to the Centers for Disease Control and Prevention (2019), the 
incidence rate of melanoma was 21.5 per 100,000 people in Colorado with an average 
of 1,274 new cases of melanoma in 2016.  Out of the new cases of melanoma, there 
were about 746 men and 528 women.  In 2016, approximately 141 deaths were due to 
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melanoma in Colorado (Centers for Disease Control and Prevention, 2019).  The 
incidence rate of melanoma was highest among Whites with 23.3 per 100,000 people 
and lowest among Hispanics with 5.1 in 2016 (Centers for Disease Control and 
Prevention, 2019).  The incidence rates of melanoma among White males and White 
females were 29.2 per 100,000 people and 18.8 per 100,000 in Colorado in 2016 
(Centers for Disease Control and Prevention, 2019).  The American Cancer Society 
(2018a) estimated there will be 26,800 new cases of melanoma in the state of 
Colorado in 2019 with estimated deaths of 8,120.  Coloradans are at the highest risk 
for melanoma due to ultraviolet radiation with elevation, 300 plus days of sunshine, 
and love for outdoors; as a result, the Colorado Melanoma Foundation (2018) ranked 
Colorado as one of the highest states for skin cancer incidence and mortality rates.  
Melanoma Screening Guidelines 
Melanoma is a challenging disease for clinicians to treat due to potential 
mortality with delayed recognition and a high incidence of its benign counterpart, 
melanocytic nevus (Argenziano et al., 2013).  Thus it is essential that melanoma is 
identified early so that the appropriate treatment can be identified.  There are several 
clinical guidelines for melanoma screening; however, those guidelines are not 
routinely used in primary care due to inconsistencies among the recommendations for 
melanoma in primary care, costs, and time.  The U.S. Preventive Services Task Force 
(2016) concluded there was insufficient evidence to assess the benefits and harms of 
visual skin examination by a clinician for primary- or population-level screening 
among asymptomatic adults.  However, providers should be aware of the risk factors 
of melanoma and any suspicious lesions should be biopsied (U.S. Preventive Services 
Task Force, 2016).  Other national organizations have their own screening guidelines 
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for melanoma such as the American Cancer Society, American Academy of 
Dermatology, and Skin Cancer Foundation.  However, none of those guidelines 
provide a step-by-step approach (algorithm) to identify an at-risk population for 
melanoma that is evidence-based, comprehensive, and easy to implement in a primary 
care setting.  
Risk Prediction Model 
for Melanoma 
With any pigmentation and lesions on the skin, the diagnosis of melanoma 
should be considered.  The targeted screening of high-risk individuals for melanoma is 
feasible, economical with high specificity, and decreases unnecessary procedures and 
patient anxiety as compared to the screening of the entire population (Williams, Shors, 
Barlow, Solomon, & White, 2011).  To assess the risk of melanoma, there are 
prediction models for providers and patients.  The risk prediction model can be helpful 
at improving the identification of people at high risk for melanoma (Usher-Smith, 
Emery, Kassianos, & Walter, 2014).  
However, the self- assessment models of melanoma by the patients decrease 
the healthcare costs and person power compared to the risk assessment by healthcare 
providers.  In addition to the self-assessment models for melanoma, other techniques 
can be used by healthcare providers such as asymmetry, border irregularity, color that 
is not uniform, diameter greater than 6 mm, and evolving size, shape, or the color 
(ABCDE) rule; ugly duckling sign; and the Glasgow 7-point checklist.  
Self-assessment of melanoma risk score.  The self-assessment of melanoma 
risk score (SAMScore) was created by the West Melanoma Network that consisted of 
a French network of dermatologists, general practitioners, and nurses (Quereux et al., 
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2012).  The questions on the risk score were developed using the risk factors 
associated with melanoma.  It has a total of seven questions: phototype, number of 
melanocytic nevi, freckling tendency, severe blistering sunburn during childhood or 
teenage years, life in a country at low latitude, a history of previous personal 
melanoma, and a history of melanoma in a first degree relative (Quereux et al., 2012).  
The questions in the risk score are written in a very simple language so that people 
without medical knowledge will be able to comprehend and provide answers to the 
questions.  The risk score is designed so that the high-risk individuals for melanoma 
can be identified (Quereux et al., 2012).  Based on the answers, the patients are 
identified as high risk or positive SAMScore if at least one of the three criteria is 
verified (Quereux et al., 2012).  The criteria are listed as follows:  
 First criterion: Presence of at least three risk factors among the seven 
following risk factors i:e phototype I or II, freckling tendency, number 
of melanocytic nevi > 20 on both arms, severe sunburn during 
childhood or teenage years, life in a country at low latitude, a history of 
Previous melanoma, a history of melanoma in a first degree relative. 
 Second criterion: A patient under 60 years of age and a number of 
melanocytic nevi > 20 on both arms.  
 Third criterion: A patient of 60 years old or over and a freckling 
tendency. (Quereux et al., 2012, p. 589) 
 
Mackie scoring system.  The Mackie scoring system consists of four 
independent risk factors for melanoma such as freckles, moles, atypical nevi, and 
history of severe sunburn (Jackson, Wilkinson, Ranger, Phil, & August, 1998). There 
are four risk groups based on the questionnaires in the Mackie scoring system: 
marginally increased risk, increased risk, very increased risk, and worryingly high risk 
(Jackson et al., 1998). 
Williams model.  This model is a self- assessed clinical risk estimation model 
for melanoma that is used to identify people at higher risk for melanoma.  The model 
9 
 
includes seven risk factors: sex, age, natural hair color at age 15 years, number of 
severe sunburns aged 2 to18 years, prior nonmelanoma skin cancer, number of raised 
moles on both arms, and density of freckles on arms before age 20 (Usher-Smith et al., 
2016). The risk score ranges from 0 to 67 (Usher-Smith et al., 2016).  
Brief cancer risk assessment tool.  This assessment tool is a self-administered 
instrument to assess skin cancer risk.  This tool includes risk factors for melanoma and 
other keratinocyte skin cancers: ethnicity; personal and family history of skin cancer; 
mole count; freckles; childhood residence; sunburn history; and sun sensitivity factors 
such as skin color, natural hair color, and ease of sunburn and tanning (Glanz et al., 
2003).  
Melanoma risk assessment tool.  The melanoma risk assessment tool is an 
online assessment tool developed by the National Cancer Institute (n.d.a) for 
healthcare professionals to estimate the absolute risk of developing invasive 
melanoma.  The tool is for non-Hispanic Whites ages 20 to 70 years (National Cancer 
Institute, n.d.a).  Also, patients with at least one of the diagnoses of melanoma, or 
melanoma in situ or non-melanoma skin cancer, and/or a family history of melanoma 
should not use this tool to estimate their risk of developing melanoma (National 
Cancer Institute, n.d.a).  The tool consists of demographics (race, age, location, and 
gender), skin characteristics (complexion and sun exposure), and physical exam (size 
of moles and freckling tendency) (National Cancer Institute, n.d.a).  
Unsupervised self-assessment of melanoma.  This tool consists of questions 
on melanoma risk factors: skin type, eye color, hair color, total number of nevi, 
presence of congenital nevi, skin damage due to solar radiation, history of sunburns, 
and family history of melanoma (Harbauer, Binder, Pehamberger, Wolff, & Kittler, 
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2003).  Even though the unsupervised questionnaire is helpful in identifying 
individuals at high risk for melanoma, it has low accuracy, which limits the 
practicability of the questionnaire (Harbauer et al., 2003).  
Asymmetry, border irregularity, the color that is not uniform, diameter 
greater than 6 mm, and evolving size, shape, or color rule.  The ABCDE rule is 
widely used by family practice providers while looking at the simple morphologic 
appearance of the lesion.  The detailed description of the ABCDE rule is below: 
 A = Asymmetry 
Melanoma lesions or moles are not symmetrical and are irregular. 
 B = Border 
Melanoma lesions or mole have irregular borders and are hard to 
define.  
 C = Color 
Melanoma lesions or moles have more than one color such as blue, 
black, brown, tan. 
 D = Diameter 
Melanoma lesions or moles are greater than 6 mm in diameter.  
 E = Evolution 
Any changes in the color and size of the lesions or moles. (Melanoma 
Research Foundation, 2019, para. 3)  
 
The purpose of the rule is to assist providers in distinguishing melanoma from 
benign pigmented lesions.  The sensitivity (the ability of the test to correctly identify 
those with the disease) and specificity (the ability of the test to correctly identify those 
without the disease) of the ABCDE rule vary widely depending on the number of 
criteria for the specific lesion.  Sensitivity and specificity of the ABCDE rule range 
from 43% and 99.6%, respectively with all five criteria present and 97.3% and 36%, 
respectively with only one criterion present (Herschorn, 2012).  Thus people without 
melanoma will screen positive for melanoma when all five criteria are used, requiring 
unnecessary referrals and biopsies.  Furthermore, the opposite is true when only one 
criterion is used.  Using a rule of all five positive ABCDE criteria is great at 
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identifying a melanoma, but there is also a chance that malignant lesions can be 
missed if they do not meet all five criteria.  Thus the rule is dependent on the 
provider’s assessment of the lesions, the provider’s confidence, and the patient’s 
ability to explain the changes to the lesions.  
Ugly duckling sign.  The ugly duckling sign is another clinical approach that 
is increasingly popular at identifying a malignant lesion.  This approach is based on 
the theory that most nevi on an individual’s skin tend to resemble each other, and the 
malignant lesions appear different from their neighbors (Herschorn, 2012).  This 
approach has sensitivity and specificity of 90% and 85%, respectively, even when 
used by non-dermatologists (Scope et al., 2008).  
Glasgow 7-point checklist.  The Glasgow 7-point checklist was developed in 
1980 to help non-dermatologists identify the lesions that require further evaluation 
with dermatology referral (Walter et al., 2013).  The checklist was revised in 1989 
with three major and four minor signs of malignant melanoma.  The three major signs 
include the change in size, shape, and color.  The four minor signs include 
inflammation, crusting/bleeding, sensory change, and a diameter greater than 7 mm.  
The scoring system for this checklist was weighted with two points for major signs 
and one point for minor signs and any lesion scoring greater or equal to three 
warranted referrals to dermatologists (Walter et al., 2013).  A randomized controlled 
trial on 1,580 lesions of 1,297 participants from 15 general practices showed that the 
weighted 7-point checklist with scores greater and equal to three had the sensitivity of 
91.7% and the specificity of 33.1% for melanoma (Walter et al., 2013).  The study 
also found that the single item of the irregular border had clinically significant 
sensitivity and specificity compared to the weighted 7-point checklist at 91.3% and 
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92%, respectively (Walter et al., 2013).  This also suggests that the revision of a cut-
off score from three to greater and equal to four can improve the specificity for the 
clinically significant lesions and reduce the unnecessary referrals of the benign lesions 
without affecting the sensitivity of melanoma (Walter et al., 2013).  
Dermoscope.  A dermoscope is a noninvasive optical instrument that can help 
providers observe and accurately identify skin lesions that are not visible to the naked 
eyes (Zalaudek et al., 2008).  It has a hand-held light magnifier with a 10-fold 
magnification (Herschorn, 2012).  A meta-analysis of studies compared the diagnostic 
accuracy of the dermoscope in a clinic setting and compared it to the naked eye 
examination (Vestergaard, Macaskill, Holtis, & Menzies, 2008).  The analysis 
reviewed a total of nine studies of which two studies were randomized controlled trials 
and included 8,487 suspicious skin lesions (Vestergaard et al., 2008).  The result 
showed that the diagnostic odds ratio of the dermoscope was 15.6 times higher than 
the naked eye examination and the sensitivity of the dermoscope was 90% as 
compared to 71% of naked eye examination (Vestergaard et al., 2008).  Furthermore, 
the specificity of the dermoscope and naked eye examination did not change, 
suggesting that the dermoscope improved the accuracy of identifying melanoma 
without increasing the number of misdiagnosed melanomas (Vestergaard et al., 2008).  
Another study suggested that the dermoscope resulted in 42% fewer excisions 
compared to the naked-eye examination and had a 21% increase in specificity 
(Vestergaard et al., 2008).  
Despite the diagnostic accuracy of the dermoscope, the use of the device is 
much lower in the United States among providers as compared to other countries 
(Morris, Alfonso, & Fernandez, 2017).  A study was conducted to assess the use of the 
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dermoscope among United States providers, practice characteristics, and possible 
barriers to dermoscope use.  The study recruited 1,466 providers from 49 states in the 
United States to complete a brief cross-sectional survey (Morris et al., 2017).  The 
survey found that only 6% of providers were currently using the dermoscope in their 
clinical practice (Morris et al., 2017).  Furthermore, 54% of participants had heard of 
the dermoscope, 26% had read about it, and only 15% had used it in the past (Morris 
et al., 2017).  The barriers to incorporating the dermoscope in practice were the cost of 
the equipment, time, lack of training, and insufficient reimbursement (Morris et al., 
2017).   
Statement of the Problem 
Melanoma is on the rise with the increase in the number of mortality and 
morbidity rates.  The disease can be prevented with early detection and treatment.  
There are known environmental and genetic risk factors for melanoma.  There are 
inconsistent guidelines and recommendations on melanoma screening from several 
national and international organizations.  Even though the U.S. Preventive Services 
Task Force (2016) recommended against routine skin cancer screening, it only applies 
to asymptomatic adults without a history of premalignant or malignant skin lesions.  
There are several rationales of why skin cancer screening is important.  The U.S. 
Preventive Services Task Force concluded that increased skin cancer screening may 
result in the detection and treatment of basal cell cancer and squamous cell cancer, 
impacting life expectancy.  According to the American Cancer Society (2019a), 
squamous cell cancer causes about 2,000 deaths yearly in the United States.  As a 
result, early identification of basal cell cancer and squamous cell cancer is a more 
valuable benefit than potential harm (Johnson et al., 2017).  The U.S. Preventive 
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Services Task Force did not include any studies on morbidity associated with 
keratinocyte carcinoma and melanoma, which is a critical oversight (Johnson et al., 
2017).  Delay in the diagnosis of melanoma can result in thicker melanoma that 
requires wider excision, lymph node biopsy, lymph node dissection, and systematic 
therapy that can lead to increased morbidity (Johnson et al., 2017).   
Furthermore, keratinocyte carcinoma treatments can result in facial 
disfigurement and the functional loss with decreased quality of life (Johnson et al., 
2017).  The U.S. Preventive Services Task Force (2016) based the recommendation on 
the report from Germany’s screen program that screened about 360,288 adults for skin 
cancer with 15,983 excisions (Johnson et al., 2017).  It was estimated that one per 28 
excisions were needed to detect melanoma, which seemed to be an acceptable number 
(Johnson et al., 2017).  Thus the harm of excision seems to be overestimated by the 
U.S. Preventive Services Task Force while formulating the draft for skin cancer 
screening (Johnson et al., 2017).  There was also a difference in the type of biopsies in 
between the screening study from Germany and the United States.  In Germany, the 
biopsies were fusiform/elliptical excisional biopsies that required deep and superficial 
sutures, which is time-consuming and costly with a high morbidity rate as compared to 
shaving, cauterization, punch, and/or excision biopsies in the United States (Johnson 
et al., 2017).  Thus the differences in the types of biopsies were not included while 
making the final recommendation by the U.S. Preventive Services Task Force on 
melanoma screening, leading to the misinterpretation of procedural data and cosmetic 
outcomes (Johnson et al., 2017).  One study showed a two times higher likelihood of 
thinner melanoma being diagnosed with a skin examination by a provider and four 
times higher likelihood in men over age 60 years (Swetter, Pollitt, Johnson, Brooks, & 
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Geller, 2012).  The study was excluded due to its retrospective study design by the 
panel members of the U.S. Preventive Services Task Force.  Furthermore, there was a 
reduction of 69% in the incidence of melanoma and decreased mortality of melanoma 
with education, intervention, and screening programs at the Lawrence Livermore 
National Laboratory in Northern California (Schneider, Moore, & Mendelsohn, 2008).  
This study was excluded by the panel members of the U.S. Preventive Services Task 
Force because of the lack of generalizability to primary care (Johnson et al., 2017).  
No dermatology expert was on the panel of the U.S. Preventive Services Task Force 
who developed the guideline for skin cancer screening (Johnson et al., 2017).  
There are several melanoma self-assessment tools such as SAMScore, Mackie 
model, Williams model, brief cancer risk assessment tool, melanoma risk assessment 
tool, and unsupervised self-assessment tool.  In addition, techniques exist for providers 
to assess a lesion for melanoma and they are the ABCDE rule, ugly duckling sign, 
Glasgow 7-point scale, and dermoscope.  Each tool and technique has strengths and 
limitations; however, there is a lack of a standardized tool and technique for 
melanoma screening in the primary care settings.  
Even though providers are aware of the importance of melanoma screening, it 
is not routinely performed in the United States.  Barriers have been identified to 
effective melanoma screening in primary care.  Some of the major reasons for the lack 
of skin cancer screening in primary care include lack of confidence among primary 
care providers, low priority for skin cancer screening, lack of reimbursement, lack of 
standardized guidelines, time constraints, patient embarrassment, distraction by other 
health problems, and the perception that most of the screenings do not result in 
significant findings (Jiang et al., 2017; Oliveria, Heneghan, Cushman, Ughetta, & 
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Halpern., 2011).  It is very important that the barriers be addressed and resolved to 
solve the lack of inconsistency regarding melanoma screening.  About two-thirds of 
medical students and three-fourths of primary care residents felt they did not have 
adequate training in a total body skin examination (Johnson et al., 2017).  The 
National Health Interview Survey showed that only 8% of patients were screened for 
melanoma by their primary care providers or obstetrician/gynecologist within the last 
12 months (Johnson et al., 2017).  There is a very low screening rate for melanoma at 
16% for men and 13% for women compared to 51% for colorectal, 54% for breast 
cancer, and 43% for prostate cancer (Johnson et al., 2017).   
Historically, the detection of melanoma heavily relied on full-body skin exams 
by dermatologists.  However, in spite of a notable increase in the incidence of 
melanoma, there has not been a rapid increase in the number of dermatologists in the 
United States.  According to Schember (2015), only 13,847 dermatologists are in the 
United States, which is equivalent to a mere 1% of providers.  During a four-year 
period from 2010 to 2014, there was only a 10% increase in the number of 
dermatologists in the United States (Schember, 2015).  With the limited number of 
dermatologists, it is impossible for dermatologists to evaluate all skin conditions in a 
timely fashion.  Primary care providers are the first providers that many patients with 
suspicious skin lesions will seek in a community (Fleming, Grade, & Bendavid, 2018).  
About 41.8% of all the annual office visits are to a family practitioner or internist in 
the United States (Oliveria et al., 2011).  Thus primary care providers play an essential 
role in the early detection of melanoma by performing diagnostic biopsies of 
suspicious skin lesions or referring patients to dermatologists for further evaluation 
(Fleming et al., 2018).  
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Thus a standardized evidence-based and comprehensive melanoma screening 
tool or technique is needed that can be utilized by primary care providers to screen 
individuals at high-risk for melanoma.  Education regarding melanoma screening is 
needed among primary care providers and the general population.  It is very important 
that barriers identified by primary care providers be addressed and resolved to solve 
the lack of inconsistency regarding melanoma screening.  
Purpose of the Project 
The burden of melanoma screening relies heavily on primary care providers 
due to the inadequate number of dermatologists in the United States.  However, 
primary care providers do not perform melanoma screening due to time constraints, 
lack of training, lack of standardized guidelines, and the complexity of a patient’s 
medical issues.  The purpose of this scholarly project was to implement an evidence-
based melanoma screening algorithm using SAMScore to identify patients at high risk 
for melanoma in a primary care setting by primary care providers in an effort to 
facilitate early detection and initiate treatments to minimize the complications related 
to melanoma.  The SAMScore was chosen over the other assessment tools and 
techniques because it is a validated assessment tool for healthcare providers at 
identifying high-risk patients for melanoma, and it requires 11.54 times fewer patients 
to detect a new case of melanoma as compared to a non-targeted screening (Quereux 
et al., 2012).  
Patient Population, Intervention, Comparison/ 
Intervention, Outcome Question, and Time 
 
 Primary care providers play an important role in the identification of patients 
who are at high risk for melanoma.  Even though the primary screening for melanoma 
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for the general population is not recommended by the U.S. Preventive Services Task 
Force (2016), a targeted melanoma screening has been recommended to identify high-
risk patients for melanoma for early diagnosis and survival (Curiel-Lewandroski, 
Chen, & Swetter, 2013).  Melanoma is a curable disease if diagnosed early, and the 
people at high-risk are not routinely screened for this disease which is a major 
problem.  Since the SAMScore is a validated tool, this tool was utilized to screen high-
risk patients for melanoma in this scholarly project.  Also, an evidence-based 
algorithm was developed by the project lead.  The patient population, intervention, 
comparison/intervention, outcome, and time (PICOT) question format was used to 
develop the clinical question in the evidence-based quality improvement project. Thus 
the following PICOT question was developed by the project lead to assess if the 
algorithm yielded an increase in the number of melanoma screening for high-risk 
patients by the primary care providers in a primary care setting.  
Q1 In English speaking adult patients (ages 35 to 75 years), attending 
annual wellness visits in a primary care setting, how does the use of a 
melanoma screening algorithm for providers including risk-
stratification questionnaire, compared with usual practice (no provider 
workflow, algorithm, or structured screening recommendation) affect 
identification of patients at high-risk of melanoma (and therefore 
likelihood of future evidence-based clinical interventions of skin cancer 
diagnosis and treatment) during a one-month intervention period as 
compared to one-month pre-intervention period in the same practice? 
 
Definition of Terms 
Familial atypical multiple mole melanoma syndrome.  It is an autosomal dominant 
genodermatosis characterized by multiple melanocytic nevi (more than 50) and 
a family history of melanoma (Mize, Bishop, Resse, & Sluzevich, 2009).  It is 
associated with the mutation of the CDKN2A gene.  
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Incidence rate.  The ratio of the number of new cases to the total time the population is 
at risk of disease (Centers for Disease Control and Prevention, 2012).  
Metastasis.  The spread of the cancer cells from where they first formed to another 
part of the body (National Cancer Institute, n.d.b). 
Odds ratio.  The odds that an outcome will occur given an exposure compared to the 
odds of the outcome occurring in the absence of that exposure (Szumilas, 
2010).  
Sensitivity.  The ability of a test to correctly classify an individual as diseased (Parikh, 
Mathai, & Thomas, 2008).  
Specificity.  The ability of a test to correctly classify an individual as disease-free 
(Parikh et al., 2008).  
Xeroderma pigmentosum.  An inherited condition characterized by an extreme 
sensitivity to ultraviolet rays from sunlight (National Institutes of Health, 
2019).  
Conclusion 
Complications of melanoma can be prevented with early diagnosis and 
treatment.  Primary care providers are in an optimal position to screen patients at high 
risk for melanoma.  Consensus on the melanoma screening guidelines is lacking in the 
United States.  An evidence-based melanoma screening model or tool or algorithm can 
be helpful to primary care providers so they can identify patients at high risk for 
melanoma.  The appropriate intervention can then be initiated for patients identified as 
high risk.  
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CHAPTER II 
 
REVIEW OF LITERATURE 
 
Synthesis of the Literature 
 
 The literature review was conducted on melanoma, historical background on 
melanoma, melanoma screening guidelines from national and international agencies, 
melanoma screening tools and techniques, barriers to melanoma screening by 
providers, interventions to melanoma screening, time to perform melanoma screening 
with and without a dermoscope, and targeted age group for melanoma screening.  The 
following electronic databases were utilized for the literature review: Academic 
Search Premier, Cochrane Central Register of Controlled Trials, Cochrane Database 
Systematic Review, Google Scholar, PubMed, and ScienceDirect.  Keywords included 
in the search were melanoma screening, primary care, skin cancer screening, cancer 
screening, melanoma screening guideline, and melanoma screening criteria.  Criteria 
included full-text articles published between 1998 and 2019 and written in the English 
language.  The study types were randomized controlled trials, systematic reviews, 
meta-analysis studies, retrospective studies, and cohort studies.  
Historical Background 
The word melanoma is derived from the Greek word “melas” meaning dark 
and “oma” meaning tumor (Rebecca, Sondak, & Smalley, 2012).  The description of 
melanoma first appeared in the literature in the writings of Hippocrates of Cos in the 
fifth century B.C. and again in the Greek physician Rufus of Eupheses (Rebecca et al., 
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2012).  The word melanoma was coined by Sir Robert Carswell in 1838 (Rebecca et 
al., 2012).  The first surgical removal of melanoma was done by the Scottish surgeon 
John Hunter at St George’s Hospital Medical School in London, and it was performed 
on a recurrent melanoma on the jaw of a 35-year-old man (Rebecca et al., 2012).  At 
that time, the surgeon did not know what he was removing.  Thus the tumor was 
preserved and was later diagnosed as melanoma in 1968 (Rebecca et al., 2012).  The 
melanoma is housed in the Hunterian Museum at Lincolns Inn Fields in London 
(Rebecca et al., 2012).   
The physical evidence of melanoma was first seen in the skeletons of Pre-
Colombian mummies (2,400 years old) from Chancay and Chingas in Peru (Rebecca 
et al., 2012).  In 1820, Dr. William Norris published a report on the etiology and 
progression of melanoma based on a study he conducted on a 59-year-old male patient 
with melanoma over three years until the man passed away (Rebecca et al., 2012).  
During the study, he found several reddish and whitish brown tints throughout the 
body (Rebecca et al., 2012).  He also found several spots of various sizes inside the 
abdomen of the man upon autopsy and noted that the man’s father passed away due to 
a similar disease (Rebecca et al., 2012).  After an in-depth study of the case, he 
concluded that the disease was hereditary in nature (Rebecca et al., 2012).  In 1857, he 
studied eight other cases of melanoma and proposed the relationship of melanoma 
with nevi and environmental factors (Rebecca et al., 2012).  In 1837, Isaac Parish 
documented the first North American case of melanoma where he described 
melanoma as “a purple mark or mole about the size of a mulberry” (Rebecca et al., 
2012, p. 116).  
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Types of Melanoma 
There are four categories of melanoma: superficial spreading melanoma, 
lentigo melanoma, acral lentiginous melanoma, and nodular melanoma.  
Superficial spreading melanoma.  This is the most common type of 
melanoma, accounting for almost 70% of all melanomas (Skin Cancer Foundation, 
2019).  This type of melanoma first appears as a flat or slightly raised, discolored 
patch with irregular borders and travels along with the top layer of skin before 
extending deep into the skin (Aim at Melanoma Foundation, 2014c; Skin Cancer 
Foundation, 2019).  These lesions commonly appear on the trunks of men, legs of 
women, and upper back of both sexes (Aim at Melanoma Foundation, 2014c).  They 
are usually diagnosed in patients between the ages of 30 and 50 years.  Half of this 
type of melanoma occurs in pre-existing moles (Aim at Melanoma Foundation, 
2014c).  The color varies from tan, brown, black, red, blue, or white.  
Lentigo melanoma.  A lentigo melanoma is a subtype of melanoma in situ, 
which is more commonly found in chronically sun-damaged skin and can progress to 
become invasive melanoma (Skin Cancer Foundation, 2019).  About 5% of all 
melanomas are lentigo melanoma (Aim at Melanoma Foundation, 2014c).  This 
melanoma is generally large, flat, and tan color, but can be black, blue, red, gray, or 
white and typically takes years to develop (Aim at Melanoma Foundation, 2014c).  
This melanoma is common in older adults on the face and other chronically sun-
exposed areas (Aim at Melanoma Foundation, 2014c).  
Acral lentiginous melanoma.  Acral lentiginous melanoma is a type of 
melanoma that stays on the surface of the skin superficially before penetrating the 
deep tissue layers (Skin Cancer Foundation, 2019).  The term acral comes from the 
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Greek word “akron,” which means extremity (Aim at Melanoma Foundation, 2014c).  
Thus this melanoma usually appears as a black or brown discoloration under the nails 
or soles of feet or palms of hands (Skin Cancer Foundation, 2019).  About 2% to 3% 
of all melanomas are acral lentiginous melanoma (Bradford, Goldstein, McMaster, & 
Tucker, 2009).  It is most common in African Americans and Asians and is the least 
common type of melanoma diagnosed among Caucasians (Skin Cancer Foundation, 
2019).  It is difficult to diagnose early because it appears like a bruise or injury to the 
palms, soles, or nail beds (Aim at Melanoma Foundation, 2014c).  
Nodular melanoma.  Nodular melanoma is a type of melanoma that is usually 
invasive and aggressive by the time it is first diagnosed (Skin Cancer Foundation, 
2019).  It first appears as blue-black, dome-shaped nodule on legs, arms, trunk, and 
scalp (Skin Cancer Foundation, 2019).  It accounts for approximately 10% to 15% of 
cases (Skin Cancer Foundation, 2019).  Thus the prognosis of the nodular melanoma is 
poor compared to other melanomas (Aim at Melanoma Foundation, 2014c).  
Summary.  Melanoma varies in its color, penetration, appearance, and 
exposure.  There are four different types of melanoma.  As a provider, it is important 
to have knowledge on all types of melanoma so that melanoma can be diagnosed as 
early as possible and appropriate intervention can be performed in a timely manner 
before the disease metastasizes to other parts and organs of the body.  
Stages of Melanoma 
 It is important for primary care providers to understand the various stages of 
melanoma as it helps them to determine treatment options and prognosis.  The 
American Joint Commission on Cancer has recommended a melanoma staging system 
that ranges from 0 through stage IV (Aim at Melanoma Foundation, 2014b).  If the 
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staging number is lower, it means the melanoma has not spread or is localized.  As the 
number increases, it means that the melanoma has spread or metastasized to other 
parts or organs of the body.  
 Stage 0 melanoma.  This is the stage of melanoma where the tumor is only on 
the epidermis layer of the skin and has not grown deeper invading surrounding tissues 
or lymph nodes or distant sites (Aim at Melanoma Foundation, 2014b).  Patients with 
this stage of melanoma are at lower risk for local recurrence or regional or distant 
metastases of the disease (Aim at Melanoma Foundation, 2014b).  This melanoma is 
also called melanoma in situ.  
 Stage I melanoma.  Stage I melanoma is differentiated into subclasses IA and 
IB.  Stage IA melanoma is melanoma with no more than a 1 mm thickness and may or 
may not have ulceration (National Cancer Institute, 2019).  Stage IB is melanoma with 
more than a 1 mm thickness, but no more than a 2 mm thickness and without 
ulceration (National Cancer Institute, 2019).  There is no evidence the tumor has 
spread to lymph nodes or metastasize to distant sites, and patients with stage I are at a 
lower risk for local recurrence of regional or distant metastases (National Cancer 
Institute, 2019).  
 Stage II melanoma.  Stage II melanoma is differentiated in subclasses IIA, 
IIB, and IIC.  Stage IIA is melanoma with a 1 to 2 mm thickness with ulceration or a 2 
to 4 mm thickness without ulceration (National Cancer Institute, 2019).  Stage IIB is 
melanoma with a 2 to 4 mm thickness with ulceration of more than a 4 mm thickness 
without ulceration (National Cancer Institute, 2019).  Stage IIC is melanoma with 
more than a 4 mm thickness with ulceration (National Cancer Institute, 2019).  
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 Stage III melanoma.  Stage III melanoma is differentiated into four 
subclasses: IIIA, IIIB, IIIC, and IIID.  Stage IIIA melanoma is less than 1 mm in 
thickness with ulceration or between a 1 to 2 mm thicknesses without ulceration 
(National Cancer Institute, 2019).  This melanoma is found in one to three lymph 
nodes by sentinel lymph node biopsy and has microsatellite tumors (tumor cells beside 
or below the primary melanoma that can be seen with a microscope), satellite tumors 
(tumor cells within 2 cm of the primary melanoma that can be seen without a 
microscope), and/or in-transit metastases (type of metastasis where cancer spreads 
through lymph vessels and grows within 2 cm from the primary melanoma) on or 
under the skin (National Cancer Institute, 2019).  Stage IIIB has three criteria.  First 
criteria stage IIIB is melanoma when the primary tumor cannot be visualized by the 
naked eye and the melanoma is found in one lymph node by a physical exam or 
imaging tests (National Cancer Institute, 2019).  The second criterion stage IIIB is 
melanoma less than 1 mm thick with ulceration or between 1 to 2 mm thick without 
ulceration with one to three lymph nodes of involvement (National Cancer Institute, 
2019).  Third criteria stage IIIB is melanoma between 1 to 2 mm thick with ulceration 
or between 2 to 4 mm thick without ulceration and one to three lymph nodes of 
involvement (National Cancer Institute, 2019).  Stage IIIC has four criteria.  First 
criteria stage IIIC melanoma cannot be seen with the naked eye and is found in two or 
three lymph nodes or one to four or more lymph nodes with microsatellite tumors, 
satellite tumors, and/or in-transit metastases on or under the skin (National Cancer 
Institute, 2019).  Second criteria stage IIIC is less than 2 mm thick with or without 
ulceration or more than 4 mm without ulceration and found in more than four lymph 
nodes or one to four lymph nodes with microsatellite tumors, satellite tumors, and/or 
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in-transit metastases on or under the skin (National Cancer Institute, 2019).  The third 
criterion stage IIIC melanoma is between 2 and 4 mm thick with ulceration or more 
than 4 mm thick without ulceration (National Cancer Institute, 2019).  This is found in 
one or more lymph nodes.  The fourth criteria stage IIIC melanoma is more than 4 mm 
thick with ulceration and found in one or more lymph nodes (National Cancer 
Institute, 2019).  Stage IIID melanoma is more than 4 mm thick with ulceration and 
found in more than two lymph nodes (National Cancer Institute, 2019).  
 Stage IV melanoma.  This is the stage of melanoma where melanoma has 
metastasized to lymph nodes distant from the primary site and spread to internal 
organs such as the liver, brain, bone, and gastrointestinal tract (National Cancer 
Institute, 2019).  The prognosis of this melanoma is poor.  
 Summary.  The stages of melanoma are a great method to understand the 
progression of the disease.  Understanding the stages of melanoma helps a provider 
formulate a treatment plan and educate the patient on their disease.  It also helps in the 
diagnosis of melanoma and determines the prognosis of the disease.  
Melanoma Genetics 
 Genes exist that predispose a person to melanoma and those genes are divided 
into low, medium, and high penetrance genes.  The penetrance of a gene refers to the 
“likelihood of a mutation carrier developing the disease over time and reflects the 
overall contribution of specific gene polymorphism, or mutation to a melanoma risk” 
(Read, Wadt, & Hayward, 2015, p. 1).  The high penetrance genes include cyclin-
dependent kinase inhibitor 2A (chromosome 9p21), cyclin-dependent kinase 4 
(chromosome 12 q14), BRCA1-assocaited protein-1 (tumor suppressor gene on 
chromosome 3p21), protection of telomeres 1 (gene that protects telomeres), 
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adrenocortical dysplasia protein homolog/telomeric repeat binding factor 2 interacting 
protein (regulates telomere length), and telomerase reverse transcriptase (catalytic 
subunit of telomerase) (Read et al., 2015).  The medium penetrance genes include 
melanocortin 1 receptor gene (encodes G-protein coupled receptor that binds alpha-
melanocyte stimulating hormone), microphthalmia-associated transcription factor (key 
regular of pigment cells including development and differentiation of melanocytes), 
and solute carrier family 45, member 2 variants (protective against melanoma and 
associated with darker skin) (Read et al., 2015).  There are several low penetrance 
genes for melanoma; however, some of the common low penetrance genes include 
Agouti signaling protein, tyrosinase, tyrosinase-related protein 1, and oculocutaneous 
albinism type II (Read et al., 2015).  Even though no single gene can guarantee 
melanoma development, presence of those genes places an individual at higher risk for 
melanoma.  It is likely that people with moderate to high genetic susceptibility require 
fewer somatic mutations before the development of melanoma (Read et al., 2015).  In 
addition, melanoma risk genes may directly or indirectly interact with the other genes 
or environmental risk factors to influence and activate melanoma growth pathways 
(Read et al., 2015).  However, the genetic testing of melanoma remains controversial 
due to the low frequency of high penetrance mutations and a combination of multiple 
other risk factors besides genes that can increase a patients’ risk for melanoma (Read 
et al., 2015).  
Melanoma Screening Guidelines 
U.S. Preventive Services Task Force melanoma screening guideline.  The 
U.S. Preventive Services Task Force (2016) concluded that the current evidence is 
insufficient to assess the balance of benefit and harm of visual skin examination by a 
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clinician to screen for skin cancer in adults.  The rating for the grade is “I” which 
means that the current evidence is lacking or of poor quality or conflicting to make the 
recommendation for the service.  However, the recommendation only applies to 
asymptomatic adults without a history of premalignant or malignant skin lesions.  
Patients with suspicious skin lesions or those under surveillance due to a high risk for 
skin cancer, such as familial syndrome, are outside the scope of this recommendation 
statement (U.S. Preventive Services Task Force, 2016).  Risk factors to melanoma, 
such as male gender, fair complexion, indoor tanning beds, personal history of 
sunburns or previous skin cancer, dysplastic nevus, multiple nevi, family history of 
melanoma, and advanced age require clinical consideration (U.S. Preventive Services 
Task Force, 2016).  The U.S. Preventive Services Task Force recommended assessing 
skin lesions using the asymmetry, border irregularity, color that is not uniform, 
diameter greater than 6 mm, and evolving size, shape or color (ABCDE) rule.  The 
screening interval for melanoma is unknown.  The treatment of melanoma after the 
detection includes excision with or without lymph node management (U.S. Preventive 
Services Task Force, 2016).  
American Academy of Dermatology.  The American Academy of 
Dermatology (2018a) recommended that high-risk individuals perform regular self-
exams to detect skin cancer early and seek an annual full-body exam.  The Academy 
encourages the general population to perform regular self-skin exams since about half 
of the melanomas are self-detected (American Academy of Dermatology, 2018b).  
Ultraviolet radiation is the most preventable risk factor for all skin cancers; thus the 
Academy recommends that everyone avoid indoor tanning beds, avoid ultraviolet rays 
by seeking shade, wear protective clothing, and use a broad-spectrum water-resistant 
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sunscreen with a sun protection factor of 30 or higher (American Academy of 
Dermatology, 2018a).  
American Cancer Society.  The American Cancer Society recommends 
cancer screening including a skin exam every three years in patients between the ages 
of 20 and 40 years and yearly screening in patients older than 40 years (Zoorob, 
Anderson, Cefalu, & Sidani, 2001).  High-risk individuals for skin cancer should have 
regular skin exams as determined by their healthcare provider (American Cancer 
Society, 2018b).  The skin exam recommendation varies by the provider and the 
number of risk factors to skin cancer (American Cancer Society, 2018b).  
American Academy of Family Physicians.  The American Academy of 
Family Physicians published a statement in 2009 stating, 
There is insufficient evidence to assess the balance of benefits and harms of 
using the whole-body skin examination by a primary care provider or patient 
skin self-examination for the early detection of cutaneous melanoma, basal cell 
carcinoma or squamous cell carcinoma in the adult general population. 
(Johnson et al., 2017, p. 23) 
 
Other organizations and associations.  The American Medical Association 
recommends an annual skin examination in patients at moderate risk for skin cancer 
and advises patients to discuss the frequency of skin cancer screening with their 
providers and perform skin self-examinations monthly (Zoorob et al., 2001).  The 
Canadian Task Force on Preventive Health Care (2018) agreed with the U.S. 
Preventive Services Task Force (2016) that insufficient evidence exists to recommend 
routine skin screening by primary care providers in low-risk patients and is a grade C 
recommendation.  However, the Canadian Task Force on Preventive Health Care 
recommended that providers counsel their patients on reducing sun exposure by using 
sunscreen and wearing protective clothing.  Thus there is an inconsistency among 
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several organizations regarding skin cancer screening guidelines and 
recommendations.   
Summary.  The various national and international organizations differ from 
each other with the recommendation for skin cancer or melanoma screening.  Some 
guidelines have recommendations for people with low, moderate, and high risk for 
melanoma; however, the guidelines are not clear on what the low, moderate, and high 
risk for melanoma entail.  While the risk factors of melanoma are listed by the U.S. 
Preventive Services Task Force (2016), other organizations do not list the risk factors 
for melanoma.  There is variability among risk factors as determined by the 
organization.  There is inconsistency in the age group and frequency of melanoma 
screening.  Even though there are differences and inconsistencies among the 
recommendations for melanoma screening, the organizations agree that high-risk 
patients need frequent melanoma screening and interventions, such as dermatology 
referral and education on ways to prevent melanoma such as clothing and sunscreen.  
Thus the above inconsistencies clearly show there is a need for a standardized method 
to identify patients who are at high-risk for melanoma.  
Risk Prediction Models 
for Melanoma 
 Self-assessment of melanoma risk score.  The survival due to melanoma is 
inversely related to the thickness of the melanoma at the time of diagnosis; thus early 
diagnosis is a key for improving the prognosis of patients with melanoma (Quereux et 
al., 2012).  Mass screening for melanoma is not recommended due to higher costs and 
lower chances of finding melanomas (Quereux et al., 2012).  Instead, the targeted 
screening is recommended to identify patients at high risk for melanoma.  A 
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prospective study was performed to assess the feasibility and validity of the self-
assessment risk factor of melanoma, also known as the self-assessment of melanoma 
risk score (SAMScore) among 46 general practitioners in the city of Nantes in the 
Pays de Loire region located in the west of France (Quereux et al., 2012).  Nantes is a 
big town with people of all skin types (Quereux et al., 2012).  Patients older than 18 
years were asked to fill out the SAMScore independently prior to being seen by the 
provider.  Approximately 7,953 patients completed the SAMScore.  Among the total 
sample population, 2,404 patients had at least one of the three criteria of the 
SAMScore verified and were identified as high-risk patients for melanoma (Quereux 
et al., 2012).  Patients were considered high-risk for melanoma if they met one of the 
criteria of the SAMScore.  For those who were identified as being at high risk for 
melanoma, providers performed a whole-body skin exam, and patients with suspicious 
lesions were then referred to dermatologists for further evaluation and biopsy as 
needed (Quereux et al., 2012).  Among 2,404 high-risk patients, 10 melanomas were 
detected (Quereux et al., 2012).  Thus the efficiency of the SAMScore was 11.54 
using the logistic model with a random effect, which means that the SAMScore was 
11.54 more efficient in detecting a new case of melanoma as compared to a non-
targeted screening tool (Quereux et al., 2012).  For the patients who did not meet the 
criteria for the SAMScore, they were not examined by the providers, which may have 
resulted in false negatives for the study (Quereux et al., 2012).  
 A randomized controlled trial was done on the French west coast to assess the 
effect of a targeted melanoma prevention intervention on patient prevention behaviors.  
The targeted population for the study was patients at high risk for melanoma as 
determined by the SAMScore with a relative risk of 11 times higher than the general 
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population (Rat et al., 2014).  A total of 20 general providers and 470 patients 
participated in the study.  Prior to the study, the providers reviewed an e-learning 
module on melanoma screening and skin exams.  Half of the providers were given 
access to the SAMScore algorithm as the intervention group, and the other half did not 
have access to the SAMScore (Rat et al., 2014).  All patients were given a SAMScore 
questionnaire to complete while they were waiting in the waiting area regardless of the 
type of visit (Rat et al., 2014).  In the intervention group, providers utilized the 
SAMScore risk calculator to determine if the patient was at high risk for melanoma 
(Rat et al., 2014).  For patients who were identified as high risk, providers performed a 
total skin examination, counseled the patient, and gave the information leaflet on 
primary and secondary prevention measures (Rat et al., 2014).  However, the control 
providers provided the information leaflet only.  
 The study suggested that the multifaceted approach by the general providers of 
identifying patients at risk, performing skin examinations, giving advice, and handing 
printed information on the prevention of melanoma had a great impact on patients 
compared to handing printed information alone.  Based on the intervention, patients in 
the intervention group were better able to recognize the risk factors to melanoma 
(71.1% versus 42.1%), more likely to perform a skin self-exam during the past 12 
months (52.6% versus 36.8%), and less likely to sunbathe during the summer (24.7% 
versus 40.8%) (Rat et al., 2014).   
 Mackie scoring system.  A case-control study was conducted by the Scottish 
Melanoma Group and Scottish Cancer Registry in 1987 to identify if clinically 
significant risk factors predicted the risk of invasive cutaneous melanoma (Mackie, 
Freudenberger, & Aitchison, 1989).  The total sample population was 371 patients 
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who were diagnosed with invasive cutaneous melanoma.  Patients were interviewed 
about their personal history of melanoma, history of melanoma in first degree 
relatives, previous residence in tropical or subtropical climates, episodes of severe 
sunburn, and use of artificial sources of ultraviolet radiation (Mackie et al., 1989).  
Patients were also examined for the number of melanocytic nevi greater than 2 mm in 
diameter, atypical nevi, and freckling tendency (Mackie et al., 1989).  Each risk factor 
was calculated for the relative risk using logistic regression analysis.  Based on the 
results, the total number of nevi was the most important risk factor (Mackie et al., 
1989).  Also, atypical nevi were present in 36% of men and 39% of females who had 
melanoma (Mackie et al., 1989).  Sixteen percent of patients had three or more 
atypical nevi compared to 1% who did not have melanoma (Mackie et al., 1989).  
Furthermore, 48% of women and 52% of men with freckles had melanoma (Mackie et 
al., 1989).  Nineteen percent of melanoma patients had a history of three or more 
episodes of severe sunburn (Mackie et al., 1989).  Thus the relative risk was calculated 
for each of the risk factors and found major risk factors: total number of nevi, number 
of atypical nevi, freckling tendency, and number of episodes of severe sunburn 
(Mackie et al., 1989).  The selection of variables for the personal risk chart used a 
forward stepwise approach based on a conditional logistic regression model, where the 
model tends to underestimate the true relative risk of melanoma from the presence of 
three or more atypical nevi and three or more episodes of severe sunburn (Mackie et 
al., 1989).  Thus even though the relative risk of the Mackie model is an acceptable 
guide to the magnitude of the risk, it may underestimate the relative risk in extreme 
cases of melanoma (Mackie et al., 1989).  Also, the model was tested among a small 
sample population of 371 patients with invasive cutaneous melanoma.  
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 Williams model.  A study was conducted to create a melanoma risk score 
based on self-assessed risk factors and determine the odds ratio for each risk factor for 
melanomas (Williams et al., 2011).  Data were collected from a case-control study of 
melanoma from Washington State (Williams et al., 2011). A total of 1,113 sample 
population with 386 cases and 727 controls aged 35 to 74 years were interviewed via 
telephone (Williams et al., 2011).  There were several variables for the model: sex, 
age, education, income, marital status, tendency to sunburn, ability to tan, number of 
severe sunburn from ages 2 to 18, natural hair color at age 15, density of freckles on 
arms before age 20, number of raised moles on both arms, prior mole removal, number 
of moles removed, and prior non-melanoma skin cancer (Williams et al., 2011).  A 
multivariate model was generated to predict the risk factors for invasive melanoma 
(Williams et al., 2011).  In the final model there were only seven risk factors: age, 
male sex, number of severe sunburns from ages 2 to18, natural hair color at age 15, 
density of freckles on the arms before age 20, number of raised moles on both arms, 
and prior non-melanoma skin cancer remained significant (Williams et al., 2011).  The 
validated area under the curve for the Williams model was 0.70, which indicated that 
the model predicts melanoma moderately well (Williams et al., 2011).  
 Brief cancer risk assessment tool.  A study was conducted to develop and 
pilot the brief cancer risk assessment tool.  The tool was developed after critically 
reviewing the literature on the risk factors and self-assessment for melanoma and basal 
cell and squamous cell cancer (Glanz et al., 2003).  The risk factors included personal 
and family history of skin cancer, total body mole count, freckles, childhood 
residence, sunburn history ethnicity, and sun sensitivity factors (Glanz et al., 2003).  
The study consisted of two pilot studies.  The first pilot study included administering 
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the questionnaire to 173 patients between the ages of 20 and 65 and without skin 
cancer (Glanz et al., 2003).  The same questionnaire was administered to those 
patients again one month later via telephone (Glanz et al., 2003).  The second pilot 
study included sending a mailed packet to 165 patients who were considered at 
moderate to high risk based on the brief risk assessment tool on their sun habits and 
sun exposures (Glanz et al., 2003).  The relative risk was calculated for each of the 
risk factors and ranged from 0.57 to 0.97.  Thus the tool was considered an acceptable 
tool for skin cancer assessment, but the validation of the tool with a clinical exam 
would have been useful (Glanz et al., 2003).  Also, the tool did not include a family 
history of melanoma as one of the risk factors, which was a limitation of the tool 
(Glanz et al., 2003). Marlene 
 Melanoma risk assessment tool.  A melanoma risk assessment tool was 
developed from a case-control study with 1,663 non-Hispanic White patients in a 
clinic from Philadelphia, Pennsylvania, and San Francisco, California (National 
Cancer Institute, n.d.a).  The tool calculated the absolute risk of the patients in 
developing invasive melanoma (National Cancer Institute, n.d.a).  The tool consisted 
of questions on race, age, location, gender, complexion, sun exposure, moles, and 
freckling tendency (National Cancer Institute, n.d.a).  The tool is available free of cost 
to the general public and providers but recommends discussing the results of the tool 
with a provider after it is completed (National Cancer Institute, n.d.a).  This tool is 
only for screening and surveillance for melanoma and is not recommended to use for 
patients with current melanoma, melanoma in situ, non-melanoma skin cancer, and 
family history of melanoma (National Cancer Institute, n.d.a).  Also, the tool is not 
validated to be used for all non-Hispanic Whites (National Cancer Institute, n.d.a).  
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 Unsupervised self-assessment of melanoma.  A case-control study was 
conducted to validate the unsupervised self-assessment of melanoma risk at the 
Department of Dermatology in Vienna (Harbauer et al., 2003).  A total of 222 patients 
had confirmed cases of primary melanoma and 220 control patients (National Cancer 
Institute, n.d.a).  Questions were administered to all participants with melanoma risk 
factors such as skin type, eye color, hair color, total number of nevi, presence of 
congenital nevi, skin damage from solar radiation, history of sunburns, and family 
history of melanoma (National Cancer Institute, n.d.a).  After the questions were filled 
out, every patient was examined by a dermatologist.  The self-assessment of risk 
factors and physician assessment of the risk factors were compared.  The areas under 
the curve for self-assessment and physician assessment were 0.73 and 0.77, 
respectively (National Cancer Institute, n.d.a).  The self-assessment was able to 
identify 39% of high- risk patients, and the physician assessment was able to identify 
42% of high-risk patients for melanoma (National Cancer Institute, n.d.a).  Even 
though the self-assessment tool was moderately valid at identifying the high-risk 
patients for melanoma, the location of the study, which was the dermatology clinic, 
limited the accuracy of the tool since most patients in a dermatology clinic may be at 
high risk for melanoma anyways (National Cancer Institute, n.d.a).  
 Summary.  All the studies on the risk prediction model had limitations and 
strengths.  The study on the Mackie scoring system was based on a very small sample 
population underestimating the relative risk of each risk factor.  The study on the 
Williams model was administered via telephone to patients who were diagnosed with 
melanoma; thus the answers may not have been accurate since the questions were 
asked by the researchers and not done by the patients themselves.  The brief 
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assessment tool was not validated among the non-Hispanic population since the 
sample size was small for the validation study.  The melanoma screening tool was an 
online tool and may not be feasible to use for those with limited computer knowledge.  
The unsupervised self-assessment tool was only moderately valid, and the location of 
the study limited the generalizability and result of the study.  Thus the SAMScore was 
chosen as the risk prediction model for this scholarly project since the validation study 
had a large sample population of 7,953, and the self-assessment questionnaire was 
followed by the primary care providers and dermatologists as needed.  Furthermore, 
the SAMScore was 11.54 times more efficient in detecting a new case of melanoma.  
Barriers to Melanoma Screening 
 A randomized survey was done to determine barriers and facilitating factors to 
full body skin exams among dermatologists and primary care providers.  The sample 
for the study was randomly selected from the American Medical Association medical 
marketing services database that included more than 30,000 office-based practicing 
providers (Oliveria et al., 2011).  Providers were categorized as family practitioners, 
internists, and dermatologists.  There were two modes of data collection: a mixed-
mode (electronic and postal mail survey) and an entirely postal mail survey (Oliveria 
et al., 2011).  The survey instrument consisted of 13 questions on demographics, 
practice characteristics, skin cancer screening behaviors, and barriers and facilitators 
to performing full-body skin exam (Oliveria et al., 2011).  Barriers to skin cancer 
screening included lack of skill or training, uncertainty about what to look for, time 
constraints, lack of proper equipment, patient embarrassment, not routinely doing skin 
assessment, lack of or inadequate reimbursement, low probability of finding cancer, 
lack of importance of skin examination, lack of standardized guidelines, low risk 
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patients for melanoma, and presence of competing comorbidities (Oliveria et al., 
2011).  Facilitators of performing a full-body skin exam include skill or expertise in 
performing an exam and diagnosing skin cancer, influence of medical training, high 
risk patients, patient demand, adequate reimbursement, medicolegal pressure to 
perform preventive procedures, completeness of patient records, and evidence 
supporting skin examination as a tool for skin cancer prevention (Oliveria et al., 
2011). The questions were graded on a 4-point scale ranging from not a factor (1) to 
major (4).  
 Out of 2,999 providers, only 1,669 providers were included in the survey with 
an overall rate of 59.2% (Oliveria et al., 2011).  Of all the respondents, more than two-
thirds of the providers stated they perform a full-body skin exam during a complete 
physical examination (Oliveria et al., 2011).  The full-body skin exam rates for 
dermatologists, family practitioners, and internists were 81.3%, 59.6%, and 56.4%, 
respectively (Oliveria et al., 2011).  The top three barriers among all disciplines were 
time constraints, competing comorbidities, and patient embarrassment or reluctance 
(Oliveria et al., 2011).  The top three facilitators included patients at high risk, patient 
demand for complete examination or mole checks, and the influence of medical 
training (Oliveria et al., 2011). 
One of the most common barriers to a full body skin exam, as reported by 
primary care providers, was time (Oliveria et al., 2011).  Zalaudek et al. (2008) formed 
a randomized multicenter study to determine the actual time required to perform a full-
body skin exam with and without a dermoscope.  There were a total of 1,359 patients 
from eight clinics in Austria, France, Germany, Italy, Spain, and the United States 
(Zalaudek et al., 2008).  Out of the total number of samples, 659 received a full-body 
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skin exam without a dermoscope, and 669 received a full-body skin exam with a 
dermoscope (Zalaudek et al., 2008).  Prior to the actual study, providers were asked to 
estimate the length of time required to perform a full-body skin exam with and without 
a dermoscope.  They estimated it takes 6.3 minutes to perform a full-body skin exam 
without a dermoscope and 10.7 minutes to perform a full-body skin exam with a 
dermoscope (Zalaudek et al., 2008).  Study results showed the actual time for a full-
body skin exam with and without a dermoscope was 2.4 minutes and 1.1 minutes, 
respectively (Zalaudek et al., 2008).  Furthermore, the length of time for a full-body 
skin exam without a dermoscope did not increase with the number of lesions and a 
minimal increase in the length of time for a full-body skin exam with a dermoscope 
with the number of lesions (Zalaudek et al., 2008).  Overall, the total duration for an 
actual full-body skin exam with or without a dermoscope was less than three minutes 
(Zalaudek et al., 2008).  
Primary care providers do not feel confident in melanoma detection and are 
overburdened with addressing other health concerns (Jiang et al., 2017).  The study 
talked about systematic and personal barriers to incorporating skin examinations in 
daily practice.  One of the most common barriers was time constraint (Jiang et al., 
2017).  Other barriers included undressing a patient for the full-body skin exam, 
uncertainty about the lesions, and workload constraints (Jiang et al., 2017).  Despite 
personal barriers, the study showed institutional barriers to implementing evidence-
based intervention of melanoma screening.  The barriers were lack of participant’s 
enthusiasm, organization’s culture, high cost of implementation, intensive time 
demands, and interaction among these factors (Jiang et al., 2017).  Thus the findings 
supported that a provider’s confidence and skills improvement are not enough; 
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planning and preparation at the institutional level are imperative for the successful 
implementation of melanoma screening. 
 In summary, skin cancer screening is important; however, there are barriers 
and facilitators to skin cancer screening in a primary care setting.  Even though time 
constraint is one of the common barriers to skin cancer screening, a randomized study 
showed a full-body skin exam takes 2.4 minutes and 1.1 minutes with and without a 
dermoscope, respectively, which is not significant as compared to the risk associated 
for melanoma (Zalaudek et al., 2008).  Other barriers include lack of confidence level 
among primary care providers.  Even though the curriculum on skin cancer screening 
showed improvement in the confidence level of the providers in detecting melanoma, 
providers may not be willing to complete the curriculum in a realistic situation in a 
clinic setting.  The Quereux et al. (2012) study with the SAMScore utilized general 
providers who were not trained in diagnosing melanoma early.  Thus the study 
concluded the SAMScore was a useful tool and could be used to identify patients at 
high risk for melanoma, and primary care providers may need to have special training 
to identify those patients.  But, the training and education on melanoma and its 
screening are always a good resource to providers.  Thus this scholarly project used a 
melanoma early detection provider toolkit as an optional resource for the providers 
instead of making the toolkit mandatory for providers, which could possibly act as a 
barrier to the project implementation.  
Melanoma Screening Interventions 
 Several programs have been developed to teach primary care providers 
melanoma risk factors, diagnosis, biopsy, and referral.  Commonly used programs are 
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a mastery learning program on melanoma, a melanoma early detection provider 
toolkit, and the informed curriculum.  
Mastery learning program.  Robinson et al. (2018) performed a randomized 
controlled trial to assess the efficacy of a mastery learning program at improving 
primary care providers’ skills in visual and dermoscope inspection.  The learning 
program had three units: visual and dermoscopic assessment, diagnosis and 
management, and deliberate practice (Robinson et al., 2018).  The program was 
developed by a team of dermatologists, primary care providers, and medical educators 
over 11 months (Robinson et al., 2018).  Of a total of 181 eligible primary care 
providers, only 90 providers were randomly chosen for the study (Robinson et al., 
2018).  They were divided into intervention and control groups.  The control group 
was given the posttest after three months without education on melanoma (Robinson 
et al., 2018).  The intervention group was given a personal identification number and a 
link to a program to complete the educational units (Robinson et al., 2018).  An 
analysis of covariance was conducted to determine the efficacy of the intervention 
(Robinson et al., 2018).  
 The primary care providers in the intervention group answered more questions 
correctly on the posttest, had no false-negative identification of melanomas, and had 
fewer false-positives than the control group (Robinson et al., 2018).  Furthermore, the 
primary care providers in the intervention group referred fewer benign lesions, greater 
melanoma lesions than the control primary care providers (Robinson et al., 2018).  As 
a result, it may significantly reduce healthcare costs, decrease patient anxiety, and 
reduce the burden of physician visits (Robinson et al., 2018).  The study also 
emphasized that opportunistic screening among at-risk patients improves the detection 
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of early melanoma without unnecessary expenses or procedures and the time burden 
for the patients (Robinson et al., 2018).  
Informed curriculum (Internet curriculum for melanoma early detection).  
The informed curriculum was developed as an educational course for primary care 
providers with a grant from the Melanoma Research Alliance (Weinstock et al., 2018).  
The goal of the curriculum was to improve the detection of skin cancer by increasing 
physician knowledge and skills on melanoma (Weinstock et al., 2018).  The 
curriculum consists of 10 case studies on the ABCDE of melanoma, ugly duckling 
signs, seborrheic keratosis, nodular melanoma, melanoma subtypes, melanoma risk 
factors, basal cell carcinoma, and dermoscopy (Weinstock et al., 2018).  
The Internet curriculum for the melanoma early detection group developed an 
interactive and online skill-based skin cancer curriculum for primary care providers to 
improve confidence and skills for skin cancer detection (Jiang et al., 2017).  The 
sample population consisted of 54 primary care providers from the two health 
maintenance organizations of the nine integrated health systems (Jiang et al., 2017).  
The training was offered as continuing medical education credits to the primary care 
providers.  After the training, primary care providers completed a 30-minute feedback 
session on the curriculum by the focus group.  Four main domains were discussed 
during the session: overall impressions of the curriculum, recommendations for 
improvement, current skin examination practices, and suggestions for increasing skin 
screening by primary care providers (Jiang et al., 2017).  
 The primary care providers thought that it was beneficial to their practice.  The 
curriculum helped to increase their confidence level at recognizing and diagnosing 
melanoma and making appropriate referrals (Jiang et al., 2017).  Some primary care 
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providers suggested the curriculum should be taught by experts (dermatologists) for 
questions and direct feedback.  
Melanoma early detection provider toolkit.  The study consisted of a self-paced 
online educational intervention for the providers regarding the melanoma screening 
using melanoma early detection provider toolkit from the Oregon Health and Science 
University (OHSU), Department of Dermatology (2001-2019).  The written 
permission was received from the OSHU to utilize the toolkit for the project as an 
optional resource for the providers (see Appendix A). The toolkit has a total of six 
sections and takes approximately three to four hours for participants to complete 
(OHSU, Department of Dermatology, 2001-2019).  The toolkit is online and is free to 
anyone wanting to learn more about melanoma.  The six sections of the toolkit include 
pretest, screening and biopsies, visual identification of melanoma versus benign, 
INFORMED case-based skin cancer education, resources for patient education, and 
final evaluation (OHSU, Department of Dermatology, 2001-2019).  The toolkit also 
provides continuing medical education for the participants.  During the educational 
intervention, participants learn about melanoma, incidence and mortality of 
melanoma, screening recommendations for high risk patients, rapid full-body skin 
exams, best practices for biopsies, practice identifying melanoma or benign lesions, 
and how to educate patients on early detection and self-exams (OHSU, Department of 
Dermatology, 2001-2019). The OHSU, Department of Dermatology partnered with 
Knight Cancer Institute and launched a public campaign called Our War on Melanoma 
on May 18, 2019.  The toolkit was designed with input from primary care and 
specialty providers in Oregon.  The vision of the toolkit was to eradicate melanoma in 
Oregon by increasing early detection and treatment and prevent deaths, suffering, and 
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high costs related to the late stage of melanoma (OHSU, Department of Dermatology, 
2001-2019).  The toolkit has the following four objectives.   
 Identify high-risk patients. 
 Apply screening recommendations. 
 Diagnose melanoma and non-melanoma skin cancer with increased 
accuracy. 
 Educate patients using provided resources. (OHSU, Department of 
Dermatology, 2001-2019, Learning objectives section) 
 
Summary.  Several educational trainings are available to primary care 
providers to improve their skin cancer screening skills and confidence levels in 
diagnosing melanoma early.  The length of the educational training plays an important 
role in having primary care providers complete the module.  Most of the educational 
trainings on melanoma are approximately two to three hours or longer, which 
discourages providers from completing the training.  As a result, they do not perform 
melanoma screening among their patient population; therefore, it is important 
educational training to be of reasonable length and have important information on 
melanoma.  Also, standardized training programs on melanoma are lacking for 
primary care providers. 
Conceptual Framework 
Avedis Donabedian, a professor at the University of Michigan, School of 
Public Health, was born to Armenian parents in 1919 in Beirut, Lebanon, and was 
raised in Ramallah, Palestine (Ayanian & Markel, 2016).  He attended medical school 
and became the director of the faculty and student health service of the American 
University in Beirut (Ayanian & Markel, 2016).  In 1953, he received a scholarship to 
study epidemiology and health services administration at the Harvard School of Public 
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Health (Ayanian & Markel, 2016).  In 1961, he joined the University of Michigan 
(Ayanian & Markel, 2016).   
In 1966, Donabedian proposed a framework using a triad of structure, process, 
and outcome to evaluate healthcare quality.  The structure was defined as the settings, 
qualifications of providers, and administrative systems through which care takes place 
(Ayanian & Markel, 2016).  In other words, the structure reflects the attributes of the 
service or provider such as staff to patient ratios and operating times of the service 
(Achieving Community Transformation Academy, n.d.).  The process was defined as 
the components of care delivered and the outcome was defined as a recovery, 
restoration of function, and survival (Ayanian & Markel, 2016).  The process 
measures reflect how the systems and processes work to deliver the desired outcome 
such as patients receiving certain standards of care or staffs washing their hands 
(Achieving Community Transformation Academy, n.d.).  The outcome measures 
reflect the impact of the process on patients and the end result of the improved process 
change such as reduced mortality, reduced the length of stay, reduced hospital-
acquired infections, and improved patients experience (Achieving Community 
Transformation Academy, n.d.).  The three proposed concepts are the foundation of 
the quality assessment in today’s world.  This concept has been used by the National 
Quality Forum, National Committee for Quality Assurance, and Medicare to assess the 
quality of healthcare (Ayanian & Markel, 2016).  
A study was done to assess the quality of care for patients boarding in the 
emergency department and to recognize the potential solutions to improve quality 
using the Donabedian conceptual model (Liu, Singer, & Camargo, 2011).  The 
structure included boarding in the emergency department such as physical 
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environment, providers’ skill set/practice/distraction, nurses’ skill set/distraction, and 
handoffs (Liu et al., 2011).  The process resulting from the structure included limited 
observation of those patients, compromise in comfort from being in the holding area 
with loud noise and without privacy, diagnosis delay/error, and therapy delay/error 
(Liu et al., 2011).  The outcome of the study included quality of care from two 
perspectives: patient and hospital.  The patient perspective included safety (adverse 
events/errors, mortality, and morbidity), timely, patient-centered, effective, equitable, 
and efficient (Liu et al., 2011).  The hospital perspective included liability and 
provider satisfaction (Liu et al., 2011).  The study showed how the Donabedian model 
illustrated the impact of certain structural problems on processes leading to poor 
outcomes while providing care to boarded patients in the emergency department (Liu 
et al., 2011).  It concluded that the model was useful as a practical framework to assess 
the quality of care of boarded patients in an emergency department so that an 
evidence-based solution could be implemented (Liu et al., 2011).  
Kobayashi, Takemura, and Kanda (2011) conducted a study to know if patient 
experiences are related to nursing services based on Donabedian’s approach.  The 
study hypothesized that classifying patient experiences related to nursing service using 
Donabedian’s approach would be useful in improving the quality of nursing care 
(Kobayashi et al., 2011).  Patient experiences were classified under the structure, 
process, and outcome (Kobayashi et al., 2011).  The structure consisted of the 
convenience of care, comfort of surroundings, and privacy (Kobayashi et al., 2011).  
The process consisted of the appropriateness of care procedures, patient–nurse 
interactions, and patient participation in the care process (Kobayashi et al., 2011).  
Outcomes of the study were changes in physical status, changes in patient knowledge, 
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and patient satisfaction (Kobayashi et al., 2011).  A total of 2,571 participants were in 
this study with an approximate 78.5% response rate (Kobayashi et al., 2011).  The 
study concluded that the Donabedian model was successful at classifying patient 
experiences related to nursing care (Kobayashi et al., 2011).  As a result, this model 
can be utilized by the practitioners, managers, and policymakers at identifying causes 
and effects of nursing practice to improve quality (Kobayashi et al., 2011).  
 The Donabedian model acted as a foundation for this scholarly project (see 
Figure 1).  The three components of the model will be discussed to improve patient 
outcomes of melanoma screening.  It was used to identify patients at high risk for 
melanoma in a rural underserved primary care clinic.  It assisted the project lead to 
assess the current structure and process of the clinic to melanoma screening and 
implement the evidence-based melanoma screening workflow algorithm to the current 
practice in order to improve patient outcomes.  
 
 
Figure 1. Donabedian model for quality of care. 
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Summary 
To summarize, the recommendation for melanoma screening of risk 
populations varies across national and international organizations.  Currently, there is 
a lack of a standardized melanoma screening recommendation, guideline, model, or 
tool to identify patients who are at high risk for melanoma.  Due to the lack of a 
systematic approach and recommendation, melanoma is not identified and diagnosed 
early, causing a delay in the treatment and an increase in mortality and morbidity 
related to melanoma.  Additionally, there are several identified barriers to melanoma 
screening leading to a lack of consistent screening in a primary care setting.  Several 
tools and techniques are used to perform melanoma screening; however, barriers to 
melanoma screening must be addressed or minimized in order to incorporate 
melanoma screening in everyday practice in primary care settings.  The Donabedian 
model acted as a foundation for this scholarly project in implementing a melanoma 
screening algorithm in a rural and underserved primary care clinic in Northern 
Colorado. 
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CHAPTER III 
 
METHODOLOGY 
 
Design 
The Doctoral Nursing Practice (DNP) scholarly project is a quality 
improvement project.  The project was carried out at one of the federally qualified 
health centers in a rural and small mountain community in northern Colorado.  The 
health center had two full-time providers and five medical assistants who participated 
in the intervention to introduce the algorithm into the primary care setting.  Out of the 
two full-time providers, one was the medical director and the other one was a 
physician assistant.  
Setting 
The project was implemented at one of the federally qualified health centers.  
This health center is the only such organization within a 30-mile radius that provides 
primary care services to publicly insured patients and to all community members, 
regardless of their ability to pay.  The health center is in a rural mountain resort 
community with a population of approximately 7,000 permanent inhabitants, with 
only three healthcare organizations and one dermatologist serving the community.  In 
2018 the health center had a 1,910-patient population with 890 males and 1,020 
females, among which 575 patients were Hispanics, 1,239 patients were Whites, and 
96 patients were unreported.  
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The health center had two full-time family practice providers who participated 
in the project protocol.  The two full-time providers and medical assistants provided 
verbal consent to participate in the project.  The patients who participated in the 
scholarly project filled out a written consent (see Appendix B) prior to filling out the 
self-assessment of melanoma risk score (SAMScore) and participating in the project.  
The clinic manager and the medical director provided written permission to conduct 
the project at the clinic (see Appendix C), and the project lead obtained approval from 
the clinic Institutional Review Board and from the University of Northern Colorado 
Institutional Review Board (see Appendices D and E).  The health center had a 
volunteer dermatologist who in the past use to see patients with melanoma until 
recently when he retired from the practice.  Currently, no dermatologist was at the 
health center.  Thus non-dermatologist providers had undertaken full responsibility for 
skin cancer and melanoma screening in the clinic, in addition to many other preventive 
and treatment interventions, as referring patients to a dermatologist for skin screening 
outside the system, which can be expensive and time-consuming.  One dermatologist 
was seeing patients in the community where the clinic was located, and wait times for 
appointments could be three months or more.   
Referrals to dermatologists outside of the community would require 
approximately an hour drive each way, imposing logistical and transportation barriers 
for patients.  Since the health center served a low income and underserved population, 
cost is a huge barrier to seeing dermatologists for most patients.  Patients cannot afford 
to go to or do not have access to dermatologists for melanoma screening or routine 
skin checking; thus primary care providers play an important role in regular melanoma 
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screening.  It is vital that primary care providers assess patients for melanoma risk or 
suspicious lesions during their annual exam to catch melanoma early.  
The rural mountain resort community had a population of approximately 6,352 
with a median age of 58.6 in 2018 and median household income of $53,025 in 2017 
(U.S. Census Bureau, n.d.).  The population consisted of 98.2% Whites, 7.0% 
Hispanics or Latinos, and 0.8% two or more races with 6.92% of the people who 
spoke a different language other than English as their primary language (DataUSA, 
n.d.; U.S. Census Bureau, n.d.).  Spanish was the second most common language 
spoken by the people in the community with a rate of 4.72% (DataUSA, n.d.).  
Approximately 12.3% of the total population in the community lived below the 
poverty line (U.S. Census Bureau, n.d.).  In 2014, approximately 49% of males and 
52% of females were in the community (U.S. Census Bureau, n.d.).  
Sample 
 The project had two sample populations.  The first sample population included 
the two full-time providers and five medical assistants at the health center who were 
presented with the evidence-based algorithm and screening tool and completed the 
survey questionnaires.  The second sample population was the patients who qualified 
for evaluation for melanoma screening and whose charts were retrospectively 
reviewed as they met the criterion of presenting for an annual wellness visit during the 
specified duration of the project.  The targeted sample duration for the adult patients 
was one month in the control group and one month in the intervention group.  The 
primary care clinic saw approximately four to five wellness visits with new and 
established patients with approximately three to four patients who were English 
speaking in between the two providers in a day (H. Fields, personal communication, 
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May 13, 2019).  Thus the total number of patients in the project was projected to be 60 
to 80 during the intervention month.  
Inclusion Criteria 
 The sample population for patients eligible for melanoma screening included 
adult patients aged 35 to 75 years presenting for their annual physical.  Also, they 
were able to read and write in English in order to complete the SAMScore by self-
report because the SAMScore had only been validated in the English and French 
languages.  Also, the unvalidated and translated version of the tool may create 
difficulty with the interpretation of the results given a small and a non-homogenous 
sample size of the project. 
Target Age Group for Skin 
Cancer Screening 
 The comparison of melanoma was done with the other cancers with the U.S. 
Preventive Services Task Force (2016) grading of A or B to determine the age range 
for melanoma to screen.  The recommendations were based on the degree of certainty 
that the net benefit of screening was either substantial or moderately substantial even 
though the rationale for the screening age for other cancers was unclear (Johnson et 
al., 2017).  Four cancers were chosen: colorectal cancer, cervical cancer, breast cancer, 
and lung cancer.  First, the number of affected individuals with the above-mentioned 
cancers within the recommended age range was determined.  Then, the screening age 
range for the cancers was associated with age-stratified incidence, mortality rates, 
median age at diagnosis, and total percentage of incidence rates falling within that age 
range (Johnson et al., 2017).  Next, the number of affected individuals in each 
category for cancers was determined.  The age range was very similar among the 
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grade A and B cancers, and it provided a reproducible approach to define a 
recommended age range for skin cancer screening (Johnson et al., 2017).  
 For this purpose, data from the National Cancer Institute’s Surveillance, 
Epidemiology and End Results registry were used.  The study showed that the 
initiation of screening occurs at an age in which the slope of the incidence and 
mortality curves are at or near the steepest incline, and screening ends at an age in 
which the incidence and mortality curves are at or near the steepest incline (Johnson et 
al., 2017).  For melanoma, the steepest incline for the slope of the incidence and 
mortality curve was near age 35 years and the steepest decline was near age 77 years 
(Johnson et al., 2017).  Furthermore, 70% of melanoma cases fell within the 35 to 74 
years age range, 60% fell within the 45 to 74 years age range, and 86% fell within the 
35 to 84 years age range with cases from 2008 to 2012 (Johnson et al., 2017).  The 
U.S. Preventive Services Task Force (2016) suggested that the median age of 
diagnosis for melanoma to be 63 years which means that the range of possible 
initiation of screening should be somewhere between 35 and 51 years (Johnson et al., 
2017).  However, Johnson et al. (2017) suggested a slightly older termination of 
screening at age 77 years for melanoma with the initiation age being 35 years old.  
Johnson et al. stated that it seemed to be reasonable to have the screening age of 35 to 
75 years for melanoma.  
Exclusion Criteria 
 Patients were excluded who were younger than age 35 or older than 75 years 
old; were being seen for an acute problem and not for preventive care; and did not 
speak, read, and write English.  Patients presenting for a Pap smear or well-woman 
care as a chief complaint were also excluded because, per the providers at the clinic 
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these visits usually do not provide enough time for non-female reproductive exams (H. 
Fields, personal communication, May 13, 2019).  Providers usually did not perform 
any routine annual labs or address annual screenings such as colonoscopy during the 
Pap smear or well-women care visits.  Patients are usually instructed to make other 
appointments for their annual physical, where annual screening labs can be discussed 
at length and can be followed up on as needed.  
Project Mission, Vision, Objectives 
Mission 
 The mission of the project was to pilot an evidence-based melanoma screening 
algorithm into annual visits in a primary care clinic.  The project also aimed to assess 
and improve provider and clinical staff knowledge of and confidence in their ability to 
provide such screening as part of routine preventive care in this setting.  
Vision 
 The vision of this project was to increase screening for melanoma in primary 
care in order to improve patient outcomes downstream.  It is accepted that early 
detection reduces melanoma-related morbidity and mortality and primary care plays a 
crucial role in this process.  
Specific Objectives of the Project 
 Melanoma screening can be incorporated into primary care, and it decreases 
the mortality and morbidity rate related to melanoma complications.  The long-term 
goal of this scholarly project was to identify patients at high-risk for melanoma during 
adult wellness visits in a primary care setting using the evidence-based melanoma 
workflow algorithm (see Appendix F) to diagnose melanoma early for timely 
treatment in order to eventually decrease morbidity and mortality rates related to 
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melanoma and its complications.  The specific objectives for the project were as 
follows:  
1. Conduct a lunch and learn session to introduce the melanoma screening 
workflow algorithm to the providers and medical assistants at the clinic 
in mid-August 2019.  
2. Implement a pilot of evidence-based melanoma workflow algorithm for 
primary care providers and medical assistants to identify patients at 
high risk for melanoma at the clinic during the months of August and 
September 2019. 
3. Appraise the number of patients identified as high risk for melanoma 
during the intervention month of August or September and compare it 
to the control month of April at the end of September 2019. 
4. Appraise the number of patients who were positive and negative for 
SAMScore and interventions for the ones with a positive SAMScore by 
performing retrospective chart review in September 2019.  
5. Report an increase in the intention among providers and medical 
assistants of using the evidence-based algorithm in clinical practice 
compared to prior to the implementation of the algorithm.  
Project Plan 
 An informal meeting was held with the medical director and the manager of 
the primary care clinic to discuss general screening needs for the population at the 
clinic.  The providers at the clinic followed the screening recommendations and 
guidelines from the U.S. Preventive Services Task Force (2016) for the majority of the 
screening such as colorectal screening, cervical cancer screening, and breast cancer 
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screening.  The project lead expressed interest in melanoma screening and the 
importance of melanoma screening in a primary care clinic by primary care providers.  
It was mutually agreed that melanoma screening was important and could benefit the 
population of the clinic.  Primary care providers expressed that one of the major 
barriers to melanoma screening was the time and co-morbid conditions of the patients 
such as diabetes, hypertension, hyperlipidemia, and thyroid issues at the clinic.  
Primary care providers were highly qualified and knowledgeable in melanoma 
screening.  They agreed that melanoma screening could be incorporated into the 
current practice to identify patients at high risk for melanoma; however, the barriers to 
melanoma screening such as time and medical complexity should be considered.  
Melanoma Screening Algorithm 
Development 
 After the initial interview with the medical director and manager, it was 
determined that the first step of the project would be to develop an algorithm for the 
providers and staff to easily determine changes in the workflow to incorporate the 
more intentional, evidence-based melanoma screening in the clinic.  Steps of the 
algorithm development included an exhaustive literature review to determine the best 
risk prediction models, melanoma screening tools and techniques, barriers to 
melanoma screening and implementation of the risk prediction models, tools and 
techniques, and melanoma screening interventions that could be utilized to integrate 
melanoma screening in a primary care setting by the primary care providers.  After the 
review, the project lead generated a draft algorithm to be reviewed by the experts and 
clinic staff/providers.  The draft algorithm was reviewed by the medical director of the 
clinic and three advanced practice nurse practitioners to determine the validity and 
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feasibility of the algorithm and identify any potential issues with the workflow prior to 
the pilot of the project.  Once the validity of the algorithm was determined, the 
algorithm was introduced to the staff at the clinic in August 2019 and piloted during 
the months of August and September 2019.  
Staff and Provider Education 
A lunch and learn session was held at the clinic to inform the medical 
assistants and providers about the project, algorithm, outcomes measures, and plan of 
the project.  The link to the melanoma early detection toolkit for the providers (Oregon 
Health and Science University [OHSU], Department of Dermatology, 2001-2019) was 
provided to the providers as an optional available resource to melanoma screening and 
was an open-access resource.  However, providers at the clinic were fully licensed and 
were presumed to be proficient at melanoma screening, so evaluation of the 
participation in the education intervention and clinical knowledge of the providers was 
not evaluated in this scholarly project.   
The scholarly project utilized the SAMScore for melanoma screening as an 
initial screening tool that was filled out by the patients while they were waiting for the 
providers in the exam room.  Dr. Brigitte Dreno was contacted via e-mail at the skin 
cancer unit at Nantes University Hospital in France, and written consent was given to 
utilize the tool for the project (see Appendix F).  The lunch and learn session was held 
for the providers and medical assistants approximately one week prior to the 
implementation of the project.  The duration of the lunch and learn session was 
approximately 20 minutes with an additional 10 minutes for questions regarding the 
project.  The lunch and learn session included information on melanoma, mortality 
and morbidity rate of melanoma, benefits of melanoma screening on high-risk 
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individuals, melanoma screening algorithm, and role of medical assistants on giving 
the SAMScore to high-risk patients with annual visits.   
The following objectives were developed by the project lead for the lunch and 
learn session at the rural and underserved federally qualified health center:  
1. Providers would be able to identify the three criteria needed for the 
SAMScore to be positive by the end of the lunch and learn session.  
2. Providers would be able to recognize the international classification of 
diseases (ICD) 10 diagnosis code for melanoma screening by the end of 
the lunch and learn session.  
3. Providers would be able to list the keywords for the plan section of the 
subjective, objective, assessment, and plan note for a positive 
SAMScore by the end of the lunch and learn session.  
4. Providers would have an increase in the intention of utilizing the 
evidence-based algorithm by the end of the lunch and learn session.  
5. Medical assistants would be able to outline the inclusion and exclusion 
criteria for the participants of the study by the end of the lunch and 
learn session.  
6. Medical assistants would be able to summarize the steps on what to do 
with the SAMScore after the provider had reviewed it by the end of the 
lunch and learn session.  
Pilot Algorithm Implementation 
One week from the lunch and learn session the algorithm, together with the 
SAMScore, was implemented during the annual visits of all patients between the age 
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range of 35 to 75 years old and were English speakers only, as there was not a 
validated Spanish-language version of the SAMScore tool available.   
Since the SAMScore saves time and, therefore, reduces barriers for clinic staff 
to identifying patients at risk for melanoma by using self-report questionnaires, 
patients who had a limited ability to read and write were excluded from the post-
intervention group as the evidence-based algorithm requires patients to read and 
complete the SAMScore questionnaire independently before being treated by the 
provider.  The two providers were given a no signature consent form (see Appendix 
G).  The medical assistants completed the individual investigator agreement form to be 
covered under the Institutional Review Board (see Appendix H).  The medical 
assistants identified annual wellness visits that met the inclusion criteria for the 
project.  After patients were checked in by the front desk staff and were roomed by the 
medical assistants, patients were asked if they were willing to participate in the project 
by the medical assistants.  Patients who agreed to participate in the project signed the 
consent form (see Appendix B) prior to filling out the SAMScore (see Appendix I).  
The medical assistants then gave the SAMScore to the consented patients to fill out 
while they were waiting to be seen by the providers in the exam room.  The medical 
assistants instructed patients not to put any patient identifiers such as name, age, 
gender, or ethnicity in the SAMScore for privacy purposes.  The SAMscore was 
completed by the patients while they were waiting to be seen by the providers in the 
exam room.  Based on the decision tree algorithm, the providers then identified 
patients at risk for skin cancer and decided if a targeted or full-body skin exam was 
warranted.  If the patient met the criteria for risk for melanoma skin cancer based on 
their SAMScore or if the patient had concerns about a lesion meeting the ugly 
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duckling or asymmetry, border irregularity, color that is not uniform, diameter greater 
than 6 mm, and evolving size, shape or color (ABCDE) criteria, providers were 
instructed to document a diagnosis code for screening for melanoma or encounter for 
screening of malignant neoplasm of skin as ICD 10 code Z 12.83 in the patient chart.  
Next, providers documented any intervention plan related to the skin cancer or 
melanoma screening diagnosis, including but not limited to the keywords annual skin 
cancer exam or biopsy or referral to dermatology or primary prevention.  The 
completed SAMScore was collected by the medical assistants and copies of the 
SAMScore were made.  The original completed SAMScore was filed separately in a 
secure folder behind the nurse’s desk for the project lead to collect.  The copied 
SAMScore was scanned into the patient’s electronic health records.  The project lead 
accessed the charts of the patients who met the inclusion criteria but only reviewed the 
charts of patients who had consented to participate in the project and had filled out the 
SAMScore.  The connection between the patients who completed the SAMScore and 
their electronic health record was not made since the completed SAMScore did not get 
scanned into the electronic health record.   
The consent forms were stored separately in a confidential folder in a secure 
area behind the nurse’s desk.  The agreement forms and consent forms were collected 
and transmitted to the University of Northern Colorado and will be stored at the 
School of Nursing in the Scholarly Project Advisor’s office in a locked space for three 
years before they are destroyed.  
The SAMScore was printed in a bright-colored yellow paper with an ordered 
number (no patient identification was used) written on the top of the sheet so the 
project lead could keep track of all the screening tools filled out by the patients.  The 
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patients would fill out the SAMScore and have it reviewed by the providers.  After the 
SAMScore was reviewed by the providers, the bright yellow SAMScore paper was 
then copied without the patient’s identifiers by the medical assistants for the project 
lead to collect at the end of the project.  The copy was scanned into the electronic 
health record.  The original bright yellow color paper with the SAMScore was set 
aside by the medical assistants in a confidential folder in a secure area at the back of 
the nurse’s desk for the project lead to collect.  All the collected data on the 
SAMScore were confidential.  No patient identifiers were included. 
Retrospective Chart Review 
The project lead performed a retrospective chart review of the patients for the 
control month of April 2019.  According to the medical director and manager of the 
clinic (H. Fields and M. Dungan, personal communication, July 3, 2019), the 
electronic health system at the clinic did not have the ability to pull data on melanoma 
or skin cancer screening without patient identifiers.  Also, the primary complaint of 
the visit varied depending on the subjective and objective information during the 
appointment, and the providers end up doing annual screening labs and preventive 
screenings even though the primary complaint was not an annual wellness visit (H. 
Fields and M. Dungan, personal communication, July 3, 2019).  Thus the medical 
director and the manager at the clinic recommended that the project lead review each 
patient chart between ages 35 to 75 years seen by the two providers during the month 
of April 2019 irrespective of the type of the visit to obtain accurate data on the number 
of melanoma screening.  The project lead utilized a binomial method (yes/no) while 
reviewing the charts of the patients for melanoma or skin cancer screening (see 
Appendix J).  During the implementation of the project, it was identified that further 
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data were necessary to make the project stronger and robust; thus an addendum to the 
Institutional Review Board of the University of Northern Colorado was submitted and 
approved on September 12, 2019 (see Appendix K).  After the approval from the 
Institutional Review Board, the total number of annual wellness and established care 
visits were collected for the control month of April 2019.  
Intervention Chart Review 
The chart review was done for the patients who consented (see Appendix B) to the 
project during the intervention month by the project lead.  The scanned SAMScore in 
the chart of the patients was reviewed and matched with the original SAMScore as 
identified by the numbers on the top of the scanned SAMScore.  Then, the chart was 
reviewed for diagnosis in the assessment section and keywords in the plan section of 
the subjective, objective, assessment, and plan note.  The project lead identified the 
number of patients with a positive and negative SAMScore.  The project lead also 
compared the number of melanoma screenings to identify at-risk patients during the 
intervention month (August/September 2019) to the control month (April 2019).  The 
intervention chart review (see Appendix L) collected data on age, gender, number of 
patients positive for SAMScore, number of patients negative for SAMScore, number 
of patients with a melanoma screening ICD 10 code, number of patients with 
keywords in the plan note section, and number of patients who received intervention 
or education. The addendum to the Institutional Review Board of the University of 
Northern Colorado was submitted and approved on September 12, 2019.  As a result, 
the total number of annual wellness visits, establish care visits, and the number of the 
patients eligible and not eligible to participate in the study were also collected for the 
intervention months of August/September 2019.  
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The data collected from the retrospective and intervention chart review were stored 
in an encrypted file with a password, and the project lead was the only holder of the 
password.  Those data were destroyed at the end of the implementation of the project. 
Education Evaluation 
The survey questionnaires were administered to the providers and medical 
assistants before and after the lunch and learn session.  The two providers and the five 
medical assistants were given a no signature consent form.  The providers and medical 
assistants were asked to provide survey identification that included a numerical format 
of their birthday month and date.  The pre-survey questionnaire for the providers (see 
Appendix M) assessed the providers’ intention of screening patients for melanoma or 
utilizing toolkits to help them in assessing and diagnosing melanoma and if they had 
heard or learned about SAMScore.  The post-survey questionnaire for the providers 
(see Appendix N) assessed their intention to use the algorithm and toolkit, 
understanding of the SAMScore, risk factors to be considered at high risk for 
melanoma, ICD 10 code, and keywords for the plan section of the subjective, 
objective, assessment, and plan note.  It also had a space to give comments and 
feedback on barriers to screening, the algorithm, and/or their experiences with skin 
cancer screening during preventive primary care.  The post-post-survey questionnaire 
for providers (see Appendix O) was used at the end of the implementation of the 
project to assess if the staff at the clinic intended to utilize the algorithm for melanoma 
screening for the annual wellness visits in the following months.  The post-post-survey 
questions for the providers assessed their intention of utilizing the algorithm to screen 
for melanoma in the future and open-ended questions on their feedback to the project.  
The pre-survey questionnaire for the medical assistants (see Appendix P) assessed if 
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they had learned or heard about the SAMScore and specific questions about the 
SAMScore.  The post-survey questionnaire for the medical assistants (see Appendix 
Q) assessed their knowledge of the inclusion and the exclusion criteria for the 
participants of the project and their role with the completed SAMScore.  It also had a 
space to provide written comments to the open-ended questions.  The survey 
questionnaire was confidential and anonymous.  The survey questionnaire was stored 
in a confidential folder inside the office of the medical director of the clinic and was 
destroyed at the end of the project implementation.  The medical director of the clinic 
and the project lead were the only two people with access to those survey 
questionnaires.   
It was expected that the staff and providers would be able to choose the correct 
answers in the post-survey questionnaire after the lunch and learn session.  Feedback 
was used to evaluate the lunch and learn session and make changes to the 
implementation plan or algorithm as needed prior to the implementation of the 
algorithm in August/September 2019.  The feedback obtained in the post-post-survey 
question was utilized to provide the direction to improve melanoma screening in the 
future.  Table 1 shows a summary of this project using the Donabedian framework.  
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Table 1 
Summary of Project 
 
Time 
 
Structure 
 
 
Process 
 
Outcomes (patient focused) 
 
Current 
 
2 family practice providers & 5 
medical assistants  
 
FQHC 
 
Rural and underserved patient 
population 
 
No formal training or education 
on melanoma screening 
 
Historically, there was a 
dermatologist who volunteered, 
but now he has retired, and PCP 
are responsible for all 
screening. 
 
There are 1-2 dermatologists in 
the community with wait list at 
least 2-3 months. 
 
No protocol to screen patients with melanoma 
 
Melanoma screening at provider’s discretion 
depending on subjective and objective 
information.  
 
 
 
Currently, average number 
of patients screened for 
melanoma is approximately 
3 per month between two 
full time providers (H. 
Fields, personal 
communication, May 21, 
2019) 
 
Proposed 
changes 
 
Lunch and learn session 
regarding melanoma screening 
workflow algorithm for 2 full 
time providers and 5 medical 
assistants. 
 
Make changes to the 
implementation plan and 
algorithm from the feedbacks 
prior to implementation of the 
scholarly project in August/ 
September 2019 
 
 
 
 
Development of melanoma screening protocol 
from exhaustive literature and expert review.  
 
Medical assistants will identify patients to give 
the bright yellow sheet of paper with 
SAMScore who meet above mentioned 
inclusion and exclusion criteria.  
 
Medical assistants will ask patients and have 
patients sign the consent form prior to having 
them fill the SAMScore  
 
Medical assistants will instruct patients to 
complete the SAMScore while waiting to be 
seen by the providers and not to write any 
patient identifiers such as name, age, gender, 
and ethnicity on the sheet.  
 
Providers will review the sheet and determine 
if the patients are at risk for melanoma based 
on positive SAMScore and/or meeting at least 
one of the 3 criteria  
 
After patients fill out the SAMScore, sheet will 
be copied and put aside in an envelope for the 
project lead; copied sheet will then be scanned 
into patient’s medical record. 
 
For positive SAMScore, providers will 
document a relevant ICD 10 diagnosis Z12.83 
as screening for melanoma or encounter for 
screening of malignant neoplasm of skin and 
keywords in the plan section of the SOAP note: 
annual skin cancer exam or biopsy or referral to 
dermatology or primary prevention.  
 
For negative SAMScore, providers will counsel 
patients on sunscreen and exposure and provide 
handout from the American Academy of 
Dermatology. 
 
Increase in the number of 
melanoma screening at high 
risk patients age 35-75 
years old compared to 
control month through 
retrospective chart review.  
 
Increase in the number of 
referrals to dermatology or 
biopsy or education on 
ongoing care.  
 
Increase in the intention 
and attitude of providers 
and medical assistants to 
utilize algorithm at the 
clinic in the future.  
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Table 1 (continued) 
 
Time 
 
Structure 
 
 
Process 
 
Outcomes (patient 
focused) 
 
Proposed 
outcomes 
(evaluation 
of changes) 
 
The survey questionnaires for 
providers and medical 
assistants will demonstrate an 
increase in knowledge 
regarding the use of the 
evidence-based melanoma 
algorithm and its 
implementation after the 
“lunch and learn” session.  
 
 
 
Melanoma screening algorithm will be 
incorporated into the care of patients during 
their well visits as determined by chart review 
of consented patients.  
 
Providers will provide diagnosis code and plan 
in the SOAP note for those patients who have 
positive SAMScore and will be screened for 
melanoma as evidenced in the chart review of 
consented patients.  
 
 
 
90% of consented patients 
who meet the inclusion and 
exclusion criteria will 
complete SAMScore. 
 
75% of consented patients 
who score positive on the 
SAMScore will have ICD 
10 code and keywords 
listed in the plan section of 
the electronic health 
records.   
 
75% of consented patients 
who score negative on the 
SAMScore will have 
evidence of patient 
education provided in their 
electronic health record.  
 
 
Note. FQHC = federally qualified health center; ICD = international classification of 
diseases; PCP = primary care physician; SAMScore = self-assessment of melanoma 
risk score; SOAP = subjective, objective, assessment, plan. 
 
 
 
Instrumentation 
The project used two instruments: the SAMScore and survey questionnaires.   
Self-Assessment of Melanoma 
Risk Score 
The SAMScore has seven question based on the risk factors for melanoma: 
skin type, freckles, history of severe blistering sunburn as a child or adolescent, living 
in a country with intense sun exposure, personal history of melanoma, and first degree 
relative with melanoma (Quereux et al., 2012).  The patient is considered positive for a 
SAMScore if any one of three criteria is met.  The first criteria is presence of at least 
three risk factors out of the seven risk factors, the second criteria is patients younger 
than 60 years old with more than 20 melanocytic nevi on both arms, and the third 
criteria is patients older than 60 years old with freckling tendency (Quereux et al., 
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2012). The SAMScore is the tool that was filled out by patients who met the inclusion 
criteria.  It was printed on bright yellow paper with ordered numbers written on the top 
of the paper to avoid misplacement of the completed SAMScore (no patient 
identification was used).  The tool had instructions for the patients not to put any 
patient identifiers on the sheet such as name, date of birth, or gender.  After the 
SAMScore was completed by the patient, the provider reviewed the tool and evaluated 
if the patient had any one of the three criteria.  If the patient had any one of the three 
criteria, it alerted the provider that the patient was at high risk for melanoma, and thus 
a skin exam was warranted.  If the patient did not have any one of the three criteria, 
then the providers educated the patients on the primary interventions for melanoma 
and gave them the handout from the American Association of Dermatology (see 
Appendices R and S).  The completed SAMScore was then copied.  The copied 
SAMScore was scanned into the electronic health record, and the original SAMScore 
was set aside in a confidential folder behind the nurse’s desk for the project lead to 
collect.   
Survey Questionnaire 
The survey questionnaires (see Appendices M, N, O, P, and Q) were developed 
by the project lead to assess the current practice for melanoma screening at the rural 
and underserved primary care clinic and staff knowledge on the melanoma screening 
workflow algorithm for providers and medical assistants (see Appendices T and U).  
The questionnaires were given to the providers and medical assistants before and after 
the lunch and learn session.  The questionnaires were de-identified with a numerical 
format of their birthday month and date.  The pre-survey questionnaire for the 
providers (see Appendix M) had a total of nine questions with one open-ended 
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question.  Out of nine questions, five questions were scored as binomial with four 
yes/no questions, one true/false question, and three questions were multiple-choice 
with two open-ended questions.  For the pre-survey, question 5 was scored as correct 
if they answered three as the number of risk factors.  Question 6 was scored as correct 
if they answered three choices “at least 3 of the 7 risk factors, younger than 60 with 
more than 20 nevi on both arms and older than 60 with freckling tendency.”  For 
question 7, the question was scored as correct if they answered “yes” and incorrect if 
they answered “no.”  The post-survey questionnaire for the providers (see Appendix 
N) had a total of five questions with two yes/no questions, one true/false question, two 
multiple-choice questions, and one open-ended question.  For the post-survey, 
question 2 was scored as correct if they answered three as the number of risk factors.  
Question 3 was scored as correct if they answered three choices “at least 3 of the 7 risk 
factors, younger than 60 with more than 20 nevi on both arms and older than 60 with 
freckling tendency.”  Question 4 was scored as correct if they answered “yes” and 
incorrect if they answered “no.”  The post-post-survey questionnaire for the providers 
(see Appendix O) had a total of two yes/no questions and one open-ended question.  
The pre-survey questionnaire for the medical assistants (see Appendix P) had a total of 
six questions with two yes/no question, two multiple-choice questions, and two open-
ended questions.  The post-survey questionnaire for the medical assistants (see 
Appendix Q) had a total of four questions with one true/false, two multiple-choice 
questions, and one open-ended question.  For the true/false question, the question was 
scored as correct if they answered “yes” and incorrect if they answered “no.”  For the 
multiple-choice questions, the inclusion criteria for the patients to have a SAMScore 
was scored as correct if they answered three choices “patients aged 35-75 presenting 
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for their annual physical, able to read, write and speak English, English and Spanish 
speakers.”  The exclusion criteria for the patients to not have a SAMscore were scored 
as correct if they answered two choices, “patients younger than 35 and older 75 for 
acute visits and well women visits.”   
Analysis 
 For the retrospective chart review, descriptive statistics, including frequency 
and percentage, were used to describe the total number of annual visits and total 
number of melanoma screenings over the control month.  For the intervention chart 
review, descriptive statistics, including frequencies and percentages, were used to 
describe the total number of annual wellness visits, total number of establish care 
visits, total number of consented patients, total number of completed SAMScores by 
the consented patients, total number of patients positive and negative SAMScores, 
total number of patients with melanoma screening as evidenced by the ICD 10 code 
and keywords in the plan section, and total number of patients receiving interventions 
after melanoma screening.  
 Analysis of the pre-, post-, and post-post-survey questionnaire was completed 
using the descriptive statistics with percentages and frequencies.   
Duration of the Project 
An extensive literature review was performed during the months of February 
and March to develop a draft evidence-based algorithm for melanoma screening with 
an annual physical by primary care providers in a primary care setting.  The algorithm 
was validated to use for the ease of use, clarity, and accuracy by one medical doctor 
and three advanced nurse practitioners prior to the implementation of the scholarly 
project.  Then implementation of this project began with the lunch and learn session 
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with survey questionnaires to the providers and medical assistants during the month of 
August 2019.  The clinic team was asked to utilize the algorithm and SAMScore 
questionnaires starting August 7 until September 6, 2019, for a period of one month.  
The project lead retrospectively reviewed the charts of patient visits meeting inclusion 
criteria that occurred during the control or comparison month (April) and the 
intervention month (August 7 until September 6) and anticipated the completion of the 
chart review by September 2019.  The number of melanoma screenings over the 
month of August 7 and September 6 were compared to the number of melanoma 
screenings over the month of April.  
Ethical Considerations 
 The scholarly project is a quality improvement project.  The goal of the 
scholarly project was to increase the number of patients identified as high-risk for 
melanoma in the population of the primary care clinic using the project lead’s 
evidence-based melanoma screening workflow algorithm.  Even though the project 
involved the SAMScore tool that was completed by the patients, it was de-identified 
for privacy purposes for the project lead to collect.  The pre-, post-, and post-post-
survey questionnaire from the providers and staff at the clinic were confidential and 
de-identified as well.  The risks for the participants of the project were minimal.  Risks 
included potential patient embarrassment to undress or lift clothing for providers to 
assess the skin for melanoma or skin cancer.  The project would benefit the clinic and 
the patient population as this project specifically evaluated an intervention that would 
improve access to evidence-based skin cancer screening in the setting in which the 
project was being performed.  This project was submitted for review and approval 
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through the institutional review boards of the primary care clinic and the University of 
Northern Colorado to evaluate any risks to the participants.  
Project Limitations 
 One of the biggest limitations of the scholarly project was language.  The 
SAMScore is a self-reported tool and only available in the English and French 
languages, not available in the Spanish language, and was not validated in the Spanish 
language; thus the tool could only be administered to those able to read, write, and 
speak English.  Also, the clinic was a very small rural clinic with only two full time 
providers and five medical assistants.  Thus the number of staff and providers was 
another limitation of the scholarly project.  Further study is needed to see if the 
SAMScore can be translated and validated in different languages and implemented in 
a bigger clinic with a greater number of providers 
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CHAPTER IV 
DATA ANALYSIS AND RESULTS 
The overarching aim of the Doctor of Nursing Practice (DNP) scholarly project 
was to identify patients at high-risk for melanoma during the adult wellness visits in 
primary care by primary care providers using the evidence based self-assessment of 
melanoma risk score (SAMScore) and melanoma workflow algorithm in order to 
decrease mortality and morbidity rate related to melanoma and its complications.  The 
DNP scholarly project was submitted and approved by the institutional review boards 
of the University of Northern Colorado and the project clinic site on the first week of 
August 2019.  The project implementation was started on August 7, 2019, and ended 
on September 6, 2019.  
Survey Questionnaires 
The lunch and learn session was held in the conference room at the clinic.  The 
two sessions were held separately for the five medical assistants and the two 
providers.  The pre-survey questionnaires were given to the five medical assistants and 
the two providers prior to the presentation.  The medical assistants and providers were 
instructed to write the numerical format of their birth month and day on the pre-survey 
questionnaires and post-survey questionnaires.  All the medical assistants and 
providers found the presentation informative and stated that they were excited to start 
the project and see the result of the project.  It was mutually agreed between the two 
providers and the five medical assistants that the project would be implemented on the 
73 
 
same day after the lunch and learn session.  After the completion of the lunch and 
learn session, two separate folders were made for the completed consent forms and 
SAMScore and stored in a secure area behind the nurse’s desk.  Any questions 
regarding the inclusion and exclusion criteria of the project were answered.   
Pre-Survey Questionnaires 
For Medical Assistants. 
 
Out of the five medical assistants, only one medical assistant had heard about 
SAMScore because he/she had worked with a dermatologist in the past at the same 
clinic who had recently retired.  There were two other medical assistants who stated 
that they had heard or learned about the SAMScore, but they wrote in parenthesis as 
“during the presentation” (see Table 2).  Four medical assistants correctly answered 
the inclusion criteria for the patients to receive the SAMScore, which were patients 
between 35 to 75 years old presenting for their annual physical and able to read, write, 
and speak English.  Three medical assistants did not answer the exclusion criteria of 
the scholarly project incorrectly.  One medical assistant did not answer the exclusion 
criteria.  All five medical assistants correctly answered their role with the completed 
SAMScore filled by the patients (see Table 3).  None of them had any feedback or 
suggestions for melanoma screening in primary care in the pre-survey questionnaires. 
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Table 2 
Pre-Survey Questionnaires for Medical Assistants (Yes/No) 
 
Item 
 
 
Yes 
no.   % 
 
No 
no.   % 
 
 
Heard or learned about self-assessment of melanoma 
risk score (SAMScore) for melanoma screening 
 
 
 3 60 
 
 2 40 
 
 
 
 
Table 3 
 
Pre-Survey Questionnaires for Medical Assistants (Correct/Incorrect) 
 
 
Item 
 
 
Correct 
no.   % 
 
 
Incorrect 
no.   % 
 
Inclusion criteria for the patients to have the self-
assessment of melanoma risk score (SAMScore) 
 
 4 80 
 
 1 20 
 
 
Exclusion criteria for the patients to have the 
SAMScore 
 
 1 20 
 
 3 60 
 
 
Identified the role of medical assistants with the 
completed SAMSore by the patients and placing the 
copied SAMcore to be scanned into the electronic 
health record and original SAMScore in a secure folder 
to the project lead to collect 
 
 
 5 100 
 
 0 
 
 
 
 
Post-Survey Questionnaires 
For Medical Assistants 
 
After the lunch and learn sessions, all five medical assistants were able to 
correctly answer the inclusion criteria for the patients to have the SAMScore and their 
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role in making a copy of the completed SAMScore so that the copied SAMScore can 
be scanned into the medical records and original SAMScore can be set aside for the 
project lead to collect.  Only three medical assistants correctly answered the exclusion 
criteria for the patients not to have the SAMScore (see Table 4). Those medical 
assistants who did not answer the exclusion criteria correctly were re-educated on the 
inclusion and exclusion criteria prior to the implementation of the project. Also, a note 
with the inclusion and exclusion criteria was taped at the nurse’s desk.  None of the 
medical assistants had any feedback or suggestions for melanoma screening in primary 
care. 
 
Table 4 
Post-Survey Questionnaires for Medical Assistants (Correct/Incorrect) 
 
Item 
 
 
Correct 
no.   % 
 
 
Incorrect 
no.   % 
 
 
Inclusion criteria for the patients to have the self-
assessment of melanoma risk score (SAMScore) 
 
 
 5 100 
 
 0 
Exclusion criteria for the patients to have the 
SAMScore 
 
 3 60  2 40 
 
Identified the role of medical assistants with the 
completed SAMSore by the patients and placing the 
copied SAMcore to be scanned into the electronic 
health record and original SAMScore in a secure 
folder to the project lead to collect 
 
 5 100  0 
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Pre-Survey Questionnaires 
for Providers. 
Both providers answered that they did not routinely screen patients for 
melanoma and did not have a systematic method to screen patients for melanoma 
regardless of the visit types.  
On average, the percentage of the people screened for melanoma at the clinic 
was about 25% according to both providers.  Both providers had not heard or learned 
about melanoma prior to the presentation.  One provider did not answer the question 
specific to the SAMScore for the number of risk factors to make a positive SAMScore.  
The other provider answered both questions incorrectly.  Both providers were aware 
that the international classification of diseases (ICD) 10 code and keywords would be 
used by the project lead to evaluate the objectives of the scholarly project.  One 
provider had heard about the melanoma screening toolkit for providers and another 
provider had not heard or learned about any toolkit for melanoma screening (see Table 
5).  Both providers intended to use the melanoma early detection toolkit as a resource 
for melanoma screening that was provided by the project lead.  
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Table 5 
Pre-Survey Questionnaires for Providers (Yes/No) 
 
 
Item 
 
 
Yes 
no.   % 
 
 
No 
no.   % 
 
 
Do you currently screen patients for melanoma during 
their annual wellness visits? 
 
 
 0 
 
 2 100 
Heard or learned about self-assessment of melanoma 
risk score (SAMScore) for melanoma screening? 
 
 0  2 100 
Heard or Learned about melanoma early detection 
provider toolkit through Oregon Health and Science 
University (OSHU) or any toolkit for melanoma 
screening? 
 
 1 50  1 50 
Intend to use melanoma early detection provider 
toolkit as a resource for melanoma screening? 
 
 2 100  0 
 
 
Both providers provided comments to the open-ended question in the pre-
survey questionnaire.  One provider commented that time was the biggest barrier in 
performing melanoma screening and a 20-minute appointment time was not adequate; 
thus a second visit was needed for melanoma screening.  Another provider commented 
that time, multiple competing health conditions, and lack of a standardized practice 
recommendation on melanoma screening are some of the barriers to melanoma 
screening (see Tables 6 and 7).  
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Table 6 
Pre-Survey Questionnaires for Providers (Percentage) 
 
 
Item 
 
 
100% 
 
75% 
 
50% 
 
25% 
no.   % 
 
 
0% 
 
Percentage that approximates the 
number of patients currently screened 
from melanoma 
 
 
0 
 
0 
 
0 
 
2   100 
 
0 
 
 
 
 
Table 7 
 
Pre-Survey Questionnaires for Providers (Correct/Incorrect) 
 
 
Item 
 
 
Correct 
no.   % 
 
 
Incorrect 
no.   % 
 
Number of risk factors on the self-assessment of melanoma 
risk score (SAMScore) to the patients to be considered at 
risk for melanoma 
 
 
 1 50 
 
 1 50 
Criteria for positive SAMScore 
 
 1 50  1 50 
International classification of diseases ICD10 code and 
keywords will be used to evaluate the objectives 
 
 2 100  0 
 
 
 
 
Post-Survey Questionnaires 
for Providers 
Both providers intended to utilize the SAMScore and evidence-based 
algorithm in their practice to increase the number of melanoma screening among 
annual wellness visits after the lunch and learn session.  Out of the two providers, one 
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provider was able to correctly identify the number of the risk factor for positive 
SAMScore.  The same provider was able to recognize the ICD 10 code and keywords 
to evaluate the objectives of the scholarly project.  Also, both providers were willing 
to utilize the melanoma early detection provider toolkit as a resource for melanoma 
screening.  Both providers provided comments to the open-ended question in the post-
survey questionnaire.  One provider commented that time constraints of the 
appointment as a barrier to melanoma screening in primary care.  The other provider 
stated, “This seems like it will be helpful—look forward to piloting this” (see Tables 8 
and 9). 
 
Table 8 
 
Post-Survey Questionnaires for Providers (Yes/No) 
 
 
Item 
 
 
Yes 
no.   % 
 
 
No 
 
Intend to change your current practice for melanoma or skin 
cancer screening by incorporating self-assessment of 
melanoma risk score (SAMScore) or evidence-based 
melanoma algorithm? 
 
 
 2 100 
 
0 
Intend to use melanoma early detection provider toolkit as a 
resource for melanoma screening? 
 
 2 100 0 
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Table 9 
 
Post-Survey Questionnaires for Providers (Correct/Incorrect) 
 
 
Item 
 
Correct 
no.   % 
 
 
Incorrect 
no.   % 
 
 
Number of risk factors on the self-assessment of 
melanoma risk score (SAMScore) to the patients to be 
considered at risk for melanoma 
 
 
 1 50 
 
 1  50 
 
 
Criteria for positive SAMScore 
 
 1 50  1 50 
International classification of diseases (ICD) 10 code and 
keywords will be used to evaluate the objectives 
 
 2 100  0 
 
 
 
 
Post-Post-Survey Questionnaires 
for Providers 
The post-post-survey was given a week after the last day of implementation.  
Both providers replied that they intend to continue to screen patients for melanoma 
during the annual wellness visits and use the melanoma screening algorithm or 
melanoma early detection provider toolkit as a resource for melanoma screening in the 
future (see Table 10).   
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Table 10 
Post-Post-Survey Questionnaires for Providers 
 
Item 
 
 
Yes 
no.   % 
 
 
No 
 
Intend to continue to screen patients for melanoma or skin 
cancer during the annual wellness visits 
 
 
 2 100 
 
 
0 
Intend to use the melanoma screening algorithm or 
melanoma early detection provider toolkit as a resource for 
melanoma screening 
 
 2 100 0 
 
 
One of the providers said that the questionnaires in the SAMScore expedited 
the history taking to identify patients at risk for melanoma reducing the time to ask 
those questions, which was identified as one of the barriers to the melanoma screening 
at the clinic in the past.  The provider added that “the SAMScore was a great 
conversation starter even for non-melanoma skin cancer.”  Furthermore, patients who 
consented to the study and filled out the SAMScore really liked the format, the 
SAMScore, and the primary prevention handout from the American Academy of 
Dermatology.  The provider stated that the SAMScore was a great tool, and it would 
be great to have it validated in the Spanish language in the future.  The provider 
reported, “I would like to continue the study for a longer time and would love to repeat 
the study in an electronic medical record with data analytics capability [EPIC] for the 
ease of the study.”  
The other provider felt that the duration of the study was short, and the 
exclusion criteria of the study were too restrictive since the clinic had several non-
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English speaking patients.  The provider commented that the project lead did a great 
job involving the staff of the clinic.  The provider added that the study was well 
designed and increased awareness among the patients and providers on skin cancers.  
As a result, the provider screened and performed two biopsies during the intervention 
month among the patients who did not meet the criteria for the study but needed the 
screenings.  
Implementation of the Project 
 Implementation of the quality improvement project started on the day of the 
lunch and learn session upon agreement between the project lead, the two providers, 
and the five medical assistants.  Two separate folders were made by the project lead to 
collect completed consent forms and SAMScore.  The folders were placed in a secure 
place behind the nurse’s desk.  A week after the implementation of the project, an e-
mail was sent to the two providers with a link to the melanoma early detection 
provider toolkit as a resource for melanoma screening.  It was decided that additional 
data on the number of annual visits and establish care visits for the control month of 
April 2019 would make the scholarly project robust.  Also, additional data on the 
number of annual visits, establish care visits, and the percentage of patients who 
participated in the study and did not participate in the study for the intervention month 
of August/September 2019 would be important.  Thus an addendum to the data 
collection process was submitted and approved by the Institutional Review Board of 
the University of Northern Colorado on September 12, 2019.  
Throughout the implementation of the project, the medical director and the 
project lead were in contact via telephone updating the project lead on the 
implementation process and the number of screened patients.  The medical director 
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and the staff of the clinic continued to give feedback on the project.  There were a total 
of 10 patients who met the inclusion criteria for the project and only nine completed a 
SAMScore.  Out of nine completed a SAMScore, one was completed outside the 
implementation month; thus it was not included in the result of the project.  Also, one 
patient did not consent to participate in the study but completed the SAMScore.   
Retrospective Chart Review 
 The retrospective chart review for the control month of April 2019 was 
performed after the implementation of the project (see Table 11).  There were a total 
of 279 patients who were seen at the clinic during the month of April 2019 between 
the two providers.  Among the total number of patients, there were nine annual well 
visits and 18 establish care visits during the control month of April 2019 between the 
two providers.  Among the nine annual wellness visits, there was one well-woman 
visit and two well-child checkups.  Among the 18 establish care visits, there was one 
well-woman visit, one well-child checkup, and four acute problem visits.  There were 
only two patients who were screened for melanoma or skin cancer during the visit 
because both had skin concerns and had a skin check as their chief complaint of the 
visit.  Three patients had a history of melanoma, but it was not the primary diagnosis 
or chief complaint during the visit of April 2019.  
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Table 11 
Retrospective Chart Review of April 2019 
 
 
Total patients 
no. 
 
Annual visits 
no. 
 
Establish care visits 
no. 
 
Melanoma screenings 
no. 
 
 
279 
 
 
9 
 
18 
 
2 
 
 
 
Intervention Chart Review 
 The intervention chart review was started during the middle of the 
implementation month September 2019.  There were a total of 404 patients who were 
seen at the clinic in between the two providers (see Table 12).  Among those patients, 
there were 40 annual wellness visits and 29 establish care visits.  Among the 40 annual 
wellness visits, there were 18 sports physicals, nine well-child checkups, and two 
well-women visits.  Among the 29 establish care visits, there were four visits that 
turned into acute problem visits, one well-child checkup, and one well-woman visit.  
There were 10 patients who were at the clinic for annual or establish care visits, 
between ages 35 to 75 years, and able to read, write, and speak in English, making 
them eligible to participate in the scholarly project.  Out of 10 patients, only eight 
patients consented to participate in the study and completed the SAMScore.  There 
was one extra consent form from a patient to participate in the study; however, it was 
done on September 11, 2019, which was outside the intervention period.  The 
SAMScore was negative for melanoma risk for that patient.  That consent form and 
the SAMScore were not included in the result.  Also, there was one extra SAMScore 
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without a consent form, which showed that the patient who filled out the SAMScore 
was negative for melanoma risk.  Among the total of annual and establish care visits, 
there were about 59 patients who were not eligible to participate in the study.  Some of 
the reasons included younger than 35 years and older than 75 years, well-women 
visits, complex medical conditions, acute visits, and not able to speak, read, and write 
in English.  
 
Table 12 
Intervention Chart Review of August/September 2019 
 
 
Total no. of 
patients 
 
 
No. of annual 
visits 
 
No. of 
establish care 
visits 
 
No. of patients 
meeting 
inclusion criteria 
 
Number of 
patients not 
meeting criteria 
 
 
404 
 
40 
 
29 
 
10 
 
59 
 
 
 
 There were a total of eight patients who consented to participate in the study 
and completed the SAMScore.  The age range for the completed SAMScores included 
patients 38 years to 70 years out of which there were five females and three males.  
Three patients were positive for SAMScores, and five patients were negative for 
SAMScores.  Among the positive SAMScores, there were two females and one male.  
All the patients who were positive for SAMScores had ICD 10 diagnosis code as 
Z12.83, keywords (annual skin cancer exam or biopsy or referral to dermatology or 
primary prevention) and interventions (counseling and providing handout from the 
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American Academy of Dermatology) in the chart.  However, none of the patients who 
were positive for SAMScore had any suspicious lesions or skin issues during the total 
skin exam that needed skin biopsies. For five patients who were negative for 
SAMScores, two patients had ICD 10 diagnosis code as Z12.83, keywords, and 
interventions charted; two patients did not have ICD 10 diagnosis code, keywords, and 
interventions charted; and one patient had ICD 10 diagnosis code, but no keywords 
and interventions charted.  
Conclusion 
The DNP scholarly project was implemented to increase melanoma screening 
and identify patients at high risk for melanoma in a small rural clinic in northern 
Colorado.  The project utilized the SAMScore and melanoma screening algorithm.  
Prior to the implementation of the project, the clinic did not have a protocol to screen 
patients for melanoma, and it was up to a provider’s discretion to screen patients for 
melanoma depending on subjective and objective information.  With the 
implementation of the project, the melanoma screening increased from two patients 
during the control month to eight patients during the intervention month, with a 300% 
increase in melanoma screening.  Furthermore, it increased patients’ and providers’ 
awareness of melanoma and the importance of diagnosing melanoma early to prevent 
long term complications of the disease.  
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CHAPTER V 
DISCUSSION 
Melanoma is a fatal skin cancer and is on the rise.  There is a lack of a 
standardized tool and inconsistent guidelines and recommendations on melanoma 
screening for primary care providers.  Furthermore, there are an inadequate number of 
dermatologists in the United States to screen and treat people with suspected or 
diagnosed lesions or skin issues.  The majority of doctor visits are in a primary care 
setting; thus primary care providers are at an ultimate position to screen and treat 
patients with suspicious lesions, to identify if they are at high-risk for melanoma, and 
to educate patients on prevention of melanoma or nonmelanoma skin cancers. This led 
the project lead to develop an evidence-based algorithm using the self-assessment of 
melanoma risk score (SAMScore) to increase melanoma screening at a federally 
qualified health center.  The SAMScore served as a primary risk prediction model for 
the algorithm which was already validated in the English and French languages to 
identify patients at risk for melanoma.  The primary stakeholders of the project 
included five medical assistants, two providers, and consented patients.  
Project Objectives 
 The overall aim of this project was to improve melanoma screening at a 
federally qualified health center.  The data from the retrospective and intervention 
chart review demonstrated the meeting of this objective.  A review of all patient 
records during the control month of April 2019 resulted in a total of two melanoma 
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screenings.  With the implementation of this Doctor of Nursing Practice (DNP) 
scholarly project, there was an increase in the number of melanoma screenings from 
two to eight, a 300% increase in the number of melanoma screenings at this clinic. The 
following discussion outlines the results from each of the project objectives.  
Conducting the Lunch 
and Learn Session 
The first objective of this scholarly project was to develop a lunch and learn 
session, which was done during the first week of August after the approval from the 
institutional review boards of the clinic and the University of Northern Colorado.  
Two separate sessions were held for medical assistants and providers regarding 
melanoma and the implementation of the DNP scholarly project.  The pre- and post-
survey questionnaires were given to the medical assistants and the providers, and 
questions regarding melanoma and DNP scholarly project were answered.  The staff at 
the clinic was generous of their time by participating and providing their feedback. 
The staff participated in the lunch and learn session with an open and growth mindset 
to learn more about melanoma and improve patient care. 
The lunch and learn session was an effective method to have all the team 
members of the clinic together.  The project lead was able to obtain the baseline 
assessment of the understanding and knowledge of the staff on melanoma and 
melanoma screening at the clinic via pre-survey questionnaires.  Also, the staff was 
able to learn about the doctoral project including melanoma, workflow algorithm, and 
SAMScore prior to the implementation of the project.  The feedback from the staff 
during the lunch and learn session was appreciated and considered by the project lead, 
such as having a separate sheet of paper with the inclusion and exclusion criteria 
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behind the nurse’s desk for easy access.  The lunch and learn session helped in 
clarifying questions that medical assistants and providers had regarding the project 
implementation and assisted in the smooth implementation of the project.  It is highly 
recommended that a similar session to the lunch and learn session be performed prior 
to a quality improvement project in a healthcare setting.   
There was an increase in the number of correct answers for the inclusion 
criteria, exclusion criteria, and role of the medical assistants with the completed 
SAMScores while comparing the pre-survey and post-survey questionnaires for the 
medical assistants.  Previously, studies have focused on educating providers on 
melanoma and its screening, but not other staff within a clinic setting.  One study by 
Robinson et al. (2018) looked at the knowledge and skills of 89 primary care providers 
by analyzing a pretest and posttest assessment before and after completing the mastery 
learning course.  The study showed that the primary care providers in the intervention 
group were able to correctly identify melanomas in the posttest, had fewer false 
positives, and referred fewer benign lesions than the control group (Robinson et al., 
2018).  Furthermore, the mastery learning course improved the detection of early 
melanoma and patient care, decreasing unnecessary procedures, financial burdens, and 
time burdens (Robinson et al., 2018).  Similarly in this project, the providers improved 
their understanding of risk factors for melanoma and criteria for a positive SAMScore 
after the education session.  Additionally, in this project, the providers demonstrated 
an increase in the intention to continue to utilize the algorithm, SAMScore, and 
melanoma early detection provider toolkit to increase melanoma screening at the 
clinic.  No other studies were found that evaluated the intention of the providers on 
melanoma screening interventions.  
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Key facilitators.  One of the biggest facilitators for the success of the lunch 
and learn session was a positive attitude and open-mindedness of the medical 
assistants and providers to learn about melanoma and improve patient care.  In 
addition, the medical assistants and providers found the PowerPoint on melanoma, 
workflow algorithm, and SAMScore to be very helpful.  Also, any questions on the 
project were answered immediately during the session. 
Key barriers.  One of the key barriers was difficulty in finding time to have 
medical assistants and providers meet for the lunch and learn session at the same time.  
It was a challenge to have medical assistants and providers to meet the project lead at 
the same time.  Thus two separate sessions were held for medical assistants and 
providers.  Both providers had their computers with them and were charting during the 
lunch and learn session which could have affected their attention to the lunch and 
learn session.  
Implement a Pilot of Evidence- 
based Melanoma Workflow 
Algorithm 
 
After the successful lunch and learn session, the algorithm was implemented 
on the same day.  Questions from the medical assistants and providers were answered.  
The inclusion and exclusion criteria of the project were written on a paper and taped to 
the nurse’s station with a secure folder for consents and completed SAMScores per the 
request of the staff of the clinic.  The staff was informed that the project lead would be 
at the clinic twice a week during the implementation period or as needed.  The cell 
phone number of the project lead was shared with the medical director of the clinic to 
call the project lead with any questions regarding the project.  
91 
 
Throughout the implementation of the project, the medical director and the 
project lead were in contact via telephone updating the project lead on the 
implementation process and the number of screened patients.  The medical director 
and the staff of the clinic continued to give feedback on the project.  There were a total 
of 10 patients who met the inclusion criteria for the project and only nine completed 
the SAMScore.  Out of nine completed SAMScores, one was completed outside the 
implementation month; thus it was not included in the result of the project.  Also, one 
patient did not consent to participate in the study but completed the SAMScore.  Thus 
only eight completed SAMScores and eight completed consent forms were included in 
the project.   
Only eight completed SAMScores and eight completed consent forms were 
included in the DNP scholarly project.  Out of eight completed SAMScores, there 
were three patients who were positive for a SAMScore.  The providers also stated that 
the project increased their awareness of skin lesions and melanomas.  As a result, one 
provider performed two biopsies in the clinic during the intervention month.  
However, the biopsies came back negative for melanomas.  Also, no biopsies were 
performed on patients who were positive for a SAMScore since they did not have any 
suspicious lesions during the full-body skin exam.  A similar study was done using the 
SAMScore to identify the patients at high-risk or not for melanoma in France.  For 
those patients who were identified as high-risk for melanoma, they received an 
invitation via mail to consult with their primary care providers for annual skin 
examination (Rat et al., 2015).  Based on the provider’s discretion, primary care 
providers either performed total skin examination or referred patients to 
dermatologists as needed (Rat et al., 2015).  Out of 3,745 patients who received a mail 
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invitation, 61% consulted with their primary care providers and 16% consulted with a 
dermatologist (Rat et al., 2015).  There were a total of 83 patients who had suspicious 
lesions and had excisions (Rat et al., 2015).  Furthermore, there were six melanomas, 
five squamous cell carcinomas, and 15 basal cell carcinomas diagnosed (Rat et al., 
2015). 
Key facilitators. One of the key facilitators of the implementation of the 
project was the readiness of the staff and the design of the project.  The five medical 
assistants, two providers, and patients who participated in this project were eager to 
learn about melanoma, identify patients at high risk for melanoma in the community, 
improve the melanoma screening using the evidence-based melanoma workflow 
algorithm, and educate patients on the prevention of melanoma and non-melanoma 
skin cancers.  The staff at the clinic was ready to start the project and said that the 
design of the project was well planned and easy to follow.  The patients who met the 
inclusion criteria of the project were excited about the project and appreciated the staff 
for implementing such an important topic in a primary care setting. The 
implementation of the project would not have been successful if the staff and patients 
were not devoted to the project. 
Key barriers. One of the biggest barriers to the implementation of the DNP 
scholarly project was the lack of validation of the SAMScore in languages except for 
English and French.  Due to this limitation, the inclusion and exclusion criteria of the 
project were narrow and not able to include a larger number of the patient population, 
even though there were patients who might have been at higher risk for melanoma or 
non-melanoma skin conditions.  Another barrier was the size of the clinic with the 
limited number of staff.  One of the providers reported that one of the barriers to the 
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project was that it was a DNP project, and medical assistants were not as familiar with 
the rigor and details of a DNP project as compared to any clinic-based quality 
improvement project.  The provider added if it was just a quality improvement project 
rather than being a DNP project without strict rules on inclusion and exclusion criteria, 
it would have resulted into a higher number of melanoma screenings.  Attempts were 
made throughout the implementation month to educate the medical assistants 
regarding the inclusion and exclusion criteria of the project and the overall DNP 
project.  
Appraise the Number of Patients 
Identified as High Risk 
for Melanoma 
 
 The chart review was performed by the project lead for the control and the 
intervention month.  There were only two melanoma screenings that were performed 
during the control month of April 2019 between the two providers.  The melanoma 
screening increased to eight screenings during the intervention period after the 
implementation of the melanoma algorithm and the SAMScore at the clinic.  The 
patients were identified as high risk for melanoma or not based on their responses in 
the SAMScore and if they met any one of the criteria of the SAMScore.  Two other 
studies (Quereux et al., 2012; Rat et al., 2015) utilized the SAMScore to identify 
patients who were at high risk for melanoma.  The studies by Rat et al. (2015) and 
Quereux et al. (2012) identified 3,897 patients and 2,404 patients as high risk for 
melanoma, respectively, using the SAMScore.  Once they were identified as high risk 
for melanoma, they were then advised to consult with either their primary care 
providers or dermatologists (Quereux et al., 2012; Rat et al., 2015).  
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 Key facilitators. During the implementation month, the two providers and the 
five medical assistants identified the patients who met the inclusion criteria of the 
study every morning by looking at the schedule for the day.  This helped to ensure that 
all the patients meeting the inclusion criteria received the consent forms and 
SAMScore prior to being seen by the providers.  Having the SAMScore and consent 
forms in two separate colors helped to make sure that each patient received both 
during their appointment time and that those documents did not get lost during the 
process. Again, the SAMScore was very easy to read and follow and assisted 
providers to decide if the patient was at high risk for melanoma or not.  
 Key barriers. One of the barriers was the strict inclusion and criteria of the 
study for the patients to participate.  According to the staff of the clinic, there were 
patients who were interested in the study, but they did not meet the inclusion and 
exclusion criteria for the study due to language, age, and type of visit.  Another barrier 
to this DNP scholarly project was the validation of the SAMScore.  Since the 
SAMScore was only validated in the English and French languages, the model could 
not be used for people who were not able to speak, read, or write in either the English 
or French language.  Spanish was the second most common language at the clinic 
where the project was implemented, making it hard to screen the Hispanic population 
who were not able to speak, read, and write English.  
 Another important barrier was the time that providers had for one patient.  The 
providers only had 20 minutes for one patient at either acute care visits or annual 
wellness visits.  Even if the patient had an annual wellness visit as their chief 
complaint, most of the patients had several comorbid conditions or the visit ended up 
being an acute care visit, and the providers felt like they did not have time to talk 
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about melanoma screening or perform a full-body skin exam even if the patients were 
at high risk.  
Appraise the Number of Patients 
Positive and Negative for 
Self-Assessment of Mela- 
noma Risk Score and 
Interventions for the 
Ones with Positive 
Self-Assessment of 
Melanoma Risk 
Score  
 The chart review of the intervention month showed that there was a total of 
three positive SAMScores among the consented patients.  All three patients had 
keywords, international classification of diseases (ICD) 10 code and interventions 
charted in their electronic health record.  For the patients who had positive 
SAMScores and did not have any suspicious lesions or skin issues that led providers to 
perform biopsy or refer them to the dermatologists, the providers noted in the plan 
section of the electronic health record that those patients were positive for the 
SAMScore or at high risk for melanoma needing annual skin exam.  As a result, those 
patients would be followed up and would be screened for melanoma every year during 
their annual wellness visits.  If any suspicious lesion was found by the providers 
during the full-body skin examination, appropriate intervention such as biopsy or 
referral would be immediately done by the providers.  There were five patients with a 
negative SAMScore, which means that they were not at high risk for melanoma at the 
time of the visit.  Having a negative SAMScore does not mean that those patients 
would or would not have melanoma in the future.  But it is important to continue to 
screen those patients to assess their most current risk for developing melanoma using 
the SAMSocre. All the patients who were positive and negative for the SAMScore 
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received the primary prevention handout from the American Association of 
Dermatology.  The combination of the SAMScore and primary care providers’ 
examination and counseling is an efficient way to promote patient behaviors that may 
reduce melanoma risk (Rat et al., 2014).  Furthermore, identification of the patients 
who are at high risk for melanoma allows the primary care providers to focus their 
attention, energy, and time on educating those patients (Rat et al., 2014).  
 Key facilitators. The design of the project made it easier to collect the data for 
the patients who were positive and negative for SAMScore and related interventions.  
The providers were educated during the lunch and learn session to chart in the 
electronic medical record if the patients who filled out the SAMScore were positive or 
negative for the SAMScore and related interventions such as biopsy, referral, or 
annual skin exam.   
 Key barriers. As mentioned above, one of the key barriers to the appraisal of 
the number of patients positive and negative for a SAMScore was the lack of 
validation of the SAMScore in the Spanish language.  If the SAMScore would be 
validated in the Spanish language, it would broaden the inclusion criteria of the 
project, making it possible to include the Hispanic population.  This would have 
resulted in a greater number of patients screened for melanoma.  As a result, it would 
increase the number of patients who were positive and negative for a SAMScore. 
Another barrier included the short timeframe.  The implementation period of the DNP 
scholarly project was only one month, which was insufficient to assess the 
effectiveness of the project.  It would be interesting to see the result if the project 
would be implemented for a longer period of time such as six months to one year. If 
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the project was implemented for a longer period of time, it would have been possible 
to catch melanoma during that timeframe. 
Report an Increase in the Intention 
Among Providers and 
Medical Assistants 
 
 With the pre-, post-, and post-post-survey questionnaires, providers reported 
that they intend to increase the melanoma screening using the melanoma workflow 
algorithm and SAMScore.  Both providers stated that they intended to use the 
melanoma early detection provider toolkit as a resource.  One of the providers asked 
the project lead if the clinic could continue to use the printed SAMScore even after the 
intervention month to improve melanoma screening rate of the clinic.  All five medical 
assistants reported that the design of the DNP Scholarly project was well planned and 
the SAMScore was simple and easy for the patients to use with minimal to no input 
from the staff members in completing the SAMScore.  There are no studies with 
SAMScore that evaluated the intention of the staff to continue to use the SAMScore.  
This is the first project that asked specific questions on the intention of the providers 
to continue to use SAMScore and melanoma early detection provider toolkit.  
 Key facilitators. The design of the project made it easier to collect the data on 
the intention of the providers to continue to use the SAMScore, workflow algorithm, 
and melanoma early detection provider toolkit since there were yes/no questions in the 
pre-, post-, and post-post-survey.  
 Key barriers. Even though the providers stated that they intended to use the 
melanoma early detection provider toolkit in their pre-, post-, and post-post-survey, 
none of the providers had signed up or completed the toolkit by the end of the 
implementation month.  The key barrier to the lack of participation in the toolkit was 
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the time and length of the toolkit to complete all modules.  However, the providers 
reported that they would keep the toolkit in mind and would keep it as a resource for 
future reference.  
Limitations 
 The DNP scholarly project was developed and implemented with an intention 
to increase melanoma screening in a primary care setting by the primary care 
providers and improve the staff’s knowledge and confidence level at screening 
patients for melanoma.  However, one of the limitations was the duration and timing 
of the quality improvement project.  There were a lower number of patients who met 
the inclusion and exclusion criteria of the project than expected prior to the 
implementation of the project.  The duration of one month for the implementation and 
chart review was not adequate; as a result, the completed SAMScore was not scanned 
into the electronic health records for the project lead to compare with the original 
SAMScore. The whole team was extremely supportive and appreciative of 
implementing the DNP scholarly project at the clinic.  
Recommendations  
 Further study is needed to validate the SAMScore in languages other than 
English and French.  Also, the same project could be done for a longer period of time 
to evaluate the effectiveness of the SAMScore in the same clinic and compare it to the 
results of the current project.  Further study can be done if there is another risk 
prediction model that is comparable or simple, easy, and applicable in a primary care 
setting to identify patients at high risk for melanoma or skin cancers.  In addition, the 
project could easily be replicated in a clinic with a higher number of providers and 
patients.  
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 The clinic celebrates the month of May as skin cancer awareness month, where 
the clinic conducts free skin cancer screening.  Once the SAMScore is translated and 
validated in other languages, especially Spanish, it can be used to identify patients at 
risk for melanoma and can be distributed to the majority of the patients seen at the 
clinic over the month of May.  Furthermore, the primary prevention handout from the 
American Academy of Dermatology can also be used to educate patients on 
melanoma.   
In the future, it would be important to collaborate with the information 
technology department of the clinic to integrate the SAMScore into the electronic 
medical records of the patients.  The SAMScore can be laminated and used by the 
patients during their appointment, which then can be translated into the electronic 
medical record by the medical assistants.  This saves the amount of paper used for the 
SAMScore and saves time for the medical records department to scan the SAMScore 
into the charts; paper can be easily misplaced or not labeled with the correct patient’s 
identifiers.  Another recommendation would be to utilize an electronic system such as 
an Ipad with a built-in SAMScore that can still be filled out by the patient while 
waiting for providers.  This also makes it easy for the providers to access all the 
medical records of the patients rather than in the scanned document of the electronic 
medical records.  
The Donabedian model was used as a foundation for the scholarly DNP 
project.  The three frameworks of the Donabedian model, structure, process, and 
outcome, helped the project lead to assess the current structure of the clinic and 
melanoma screening process at the clinic, identify the barriers to the melanoma 
screening, develop a melanoma screening workflow algorithm for the clinic, and 
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evaluate the outcome of the implementation of the algorithm at the clinic. It is 
recommended that this model be used as a guide for future studies or projects related 
to improving melanoma screening at any facility.  
 There was a minimal budget planned for this scholarly DNP project.  The cost 
included the time of the clinic staff for the educational training sessions, time of the 
DNP student, and lunch provided at the lunch and learn session.  There were gifts, or 
monetary compensation, to the clinic staff.  The providers did not review or login into 
the melanoma early provider toolkit from the Oregon Health and Science University 
(OHSU), Department of Dermatology, since the toolkit was time-consuming.  Moving 
forward, offering an incentive to the providers to complete the education on melanoma 
might have resulted in an increased number of participations in completing the toolkit 
since the toolkit had great information on melanoma. 
Attainment of Personal Goals 
 This DNP scholarly project offered a great learning experience to the project 
lead and the staff at the clinic regarding melanoma, the importance of screening for 
melanoma, detecting melanoma early, and the important role of primary care providers 
at identifying high-risk patients for melanoma.  The project lead grew from being a 
novice student on melanoma to an expert on melanoma and its screening.  The 
limitations, barriers, and facilitators of the DNP scholarly project provided insight into 
having a standardized and evidence model to screen high-risk patients for melanoma.  
The whole process of choosing a DNP project topic to perform a literature review to 
writing all five chapters was challenging and exhausting.  Despite those limitations, 
barriers, and facilitators, the DNP scholarly project taught the project lead about 
resilience and to have a growth mindset.  
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Essentials of Doctoral Education for 
Advanced Nursing Practice 
 The American Association of Colleges of Nursing proposed that a DNP final 
project must meet the outcomes of the American Association of Colleges of Nursing 
Essentials of Doctoral Education in Advanced Nursing Practice using the five criteria 
(Waldrop, Caruso, Fuchs, & Hypes, 2014).  The five criteria are enhances, 
culmination, partnerships, implements, and evaluation.  The essentials were integrated 
into this scholarly DNP project, and the five criteria were used to demonstrate how the 
project aligned with the American Association of Colleges of Nursing Essentials of 
Doctoral Education.  
 The first criterion is enhancing health outcomes, practice outcomes, or 
healthcare policy (Waldrop et al., 2014).  This scholarly DNP project identified the 
need for melanoma screening in primary care to identify the patients at risk for 
melanoma and reduce the morbidity and mortality rate associated with it so that 
appropriate treatment could be started as soon as possible.  A literature review on 
melanoma screening was performed and the barriers to melanoma screening at the 
clinic were identified.  This led to the identification of the best risk prediction model 
for melanoma and developing a melanoma screening workflow algorithm for the clinic 
to enhance or improve patient outcomes.  
 The second criterion is reflecting a culmination of practice inquiry (Waldrop et 
al., 2014).  The project lead also identified a gap between the literature and knowledge 
that a change in melanoma screening in primary care was necessary, and it was the 
right time to bring that change.  An exhaustive literature review on melanoma 
screening was completed.  The barriers of the clinic and the providers on melanoma 
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screening were identified and, a melanoma screening workflow algorithm was 
developed that was practical and easy to implement.  The electronic medical record 
was used to perform the chart reviews of the patients for the control and intervention 
month. 
 The third criterion is requiring engagement in partnerships (Waldrop et al., 
2014).  Partnership and collaboration with the manager, providers, medical assistants, 
and patients of the clinic made the DNP scholarly project a success.  There was open 
communication between all the team members regarding the project and any questions 
were timely answered.  The project was also approved by the institutional review 
boards of the clinic and the University of Northern Colorado.  The constructive 
feedbacks were provided by the team from the start to the completion of the scholarly 
DNP project.  
 The fourth criterion is implementing or applying or translating evidence into 
practice (Waldrop et al., 2014).  The SAMScore was found to be the best, effective, 
efficient, and validated risk prediction model to identify high-risk patients for 
melanoma.  The model was used to screen patients for melanoma at the clinic.  Based 
on the literature and constructive feedback from the staff of the clinic, inclusion and 
exclusion criteria were determined.  As a result, the evidence-based melanoma 
screening workflow algorithm was developed and successfully translated into practice.  
 The last and fifth criterion is the evaluation of healthcare, practice, or policy 
outcomes (Waldrop et al., 2014).  The evaluation of the project was done after 
exhaustive literature review and implementation of the scholarly DNP project.  It was 
determined that the SAMScore was simple, easy to implement, and was an effective 
model in assessing patients’ risk for melanoma.  The project can be easily reproduced 
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and is sustainable as the clinic continues to use the SAMScore and the American 
Academy of Dermatology handout on primary prevention of melanoma even after the 
implementation month.  
Conclusion 
 The incidence and prevalence rate of melanoma is increasing worldwide, and it 
is a significant public health concern (Alendar, Drljevic, Drljevic, & Alendar, 2009).  
Melanoma is a challenging disease for a provider to detect, and it is not possible to 
perform full-body skin examination on every patient seen in a primary care clinic. 
Also, not every patient sees a dermatologist regularly to have their skin checked.  In 
addition, there is a lack of standardized guidelines on the melanoma screening that can 
be utilized in a primary care setting.   
Early detection of melanoma is important to decrease the mortality as the 
disease is highly curable at an early stage (Fleming et al., 2018).  Also, primary care 
providers can improve early the detection of melanoma directly by performing 
biopsies of suspicious lesions and referring patients to a dermatologist (Fleming et al., 
2018).  To improve early detection of melanoma, it is important that patients are 
screened for melanoma and are identified if they are at high risk for melanoma or not.   
As a result, the DNP scholarly project utilized the SAMScore and melanoma 
screening workflow algorithm at a small rural clinic in Northern Colorado with a goal 
to improve melanoma screening and identify patients at high risk for melanoma.  The 
implementation of the project showed that there was a 300% increase in the number of 
patients who were screened for melanoma during the intervention months of 
August/September 2019 compared to the control month of April 2019.  Furthermore, 
the SAMScore and melanoma screening workflow algorithm was found to be effective 
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at identifying patients at high for melanoma.  Both interventions were simple and easy 
to use with minimal to no input from the staff.  The project also improved and 
increased awareness of the staff and patients on melanoma.  Further studies are needed 
to validate the SAMScore in different languages, continue the same project for a 
longer duration, and replicate the same project in a larger clinic.  
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CONSENT FORM FOR HUMAN PARTICIPATIONS IN PROJECT 
Project Title: Screening for melanoma for at-risk population: A Practice Guide 
Researcher: Sapana Shakya, RN-BSN, Doctor of Nursing Practice Student  
Email: shak5662@bears.unco.edu 
Committee Chair: Melissa Henry, PhD, RN, FNP-C 
University of Northern Colorado, School of Nursing, Gunter Hall 3340 
Greeley, CO 80639 
Email: Melissa.Henry@unco.edu 
 
General Purpose of the study: The purpose of this project is to implement an evidence-
based melanoma screening algorithm utilizing SAMScore to identify patients at high 
risk for melanoma in a primary care setting by primary care providers in an effort to 
facilitate early detection and initiate treatments to minimize the complications related 
to melanoma.  
 
Procedure: You will be given a bright yellow sheet of paper with total of seven 
questions by the medical assistants.  You will be asked to complete the questionnaire 
independently while you are waiting to see the providers.  You will also be asked not 
to put any patient identifiers on the sheet such as name, age, sex, or ethnicity.  You 
will then hand your completed paper to the provider to review your risk for melanoma.  
Only the providers, the medical assistants, and the student project lead will have a 
record of the data collected.  The data collected will be confidential.  The original 
document will be copied, and the copy will be scanned to your medical record.  The 
original document will be stored in a confidential folder behind the nurses’ station for 
the student to collect.  The collected data will be destroyed once the project is 
completed. The project lead will review your chart for age, gender, risk factors for 
melanoma or skin cancer, documentation of melanoma or skin cancer screening, and 
intervention or education regarding melanoma or skin cancer.  
 
Disclosure risk: Potential risks to participants in this project are minimal.  Risk 
includes potential patient embarrassment to undress or lift clothing for providers to 
assess the skin for melanoma or skin cancer.  There is a minimal risk of identifying 
you as a participant since the collected document will not have any patient identifiers.  
 
Direct benefits: Direct benefits as a participant include identification as high or low 
risk for melanoma or skin cancer, early detection of skin lesions if any, and 
appropriate interventions.  Early identification of a melanoma is a lifesaver.  Another 
benefit in participating in the project is increased awareness of the risk factors for 
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melanoma and learning primary and secondary prevention measures for melanoma or 
other skin cancers.  
 
Participation: Participation in this project is voluntary.  If you wish to not participate 
in the project, you are free to do so at any time.  You may simply verbalize your wish 
to withdraw from the project by notifying the medical assistant or the providers at the 
clinic.  Your decision to participate or not participate will not affect you or your 
treatment at the clinic.  
 
Confidentiality: Your confidentiality will be protected.  There will be no patient 
identifiers attached to your completed document.  The completed document will be 
kept safe in a confidential folder at the back of the nurses’ desk.  Only the medical 
assistants, the providers and the project lead will have access to the data collected.  
 
Participation is voluntary.  You may decide not to participate in this study and if you 
begin participation you may still decide to stop and withdraw at any time.  Your 
decision will be respected and will not result in loss of benefits to which you are 
otherwise entitled.  Having read the above and having had an opportunity to ask any 
questions, please sign below if you would like to participate in this research.  A copy 
of this form will be given to you to retain for future reference.  If you have any 
concerns about your selection or treatment as a research participant, please contact 
Nicole Morse, Office of Research, Kepner Hall, University of Northern Colorado 
Greeley, CO  80639; 970-351-1910. 
 
 
_________________________   __________________________ 
Participant Printed Name:      Signature:  
 
__________________________ 
Date:  
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NO SIGNATURE CONSENT FORM FOR HUMAN PARTICIPANTS IN 
RESEARCH 
UNIVERSITY OF NORTHERN COLORADO 
 
Project Title: Screening for Melanoma for At-risk Population: A practice guide 
Researcher: Sapana Shakya, RN, BSN, FNP-DNP student 
-Phone Number: xxx-xxx-xxxx  e-mail:  shak5662@bears.unco.edu 
 
I am conducting a scholarly project to improve the number of melanoma screening for 
at risk population in a primary care clinic by the primary care providers.  As a 
participant in this project, you will be asked to complete pre-, post- and post-post 
survey questionnaires.  The pre-survey questionnaires will be given to you to complete 
prior to “the lunch and learn session”.  The post-survey questionnaires will be given to 
you to complete after “the lunch and learn session”.  The post-post survey 
questionnaires will be given to the providers only at the end of the implementation of 
the project.  All three questionnaires consist of multiple-choice questions, fill in the 
blanks and open- ended questions.  The questionnaires will assess your understanding 
of self-assessment of melanoma risk score (SAMScore) and the project algorithm.  
Each questionnaire will take approximately 3-5 minutes to complete.  
   
For the survey questionnaires, you will not provide your name, but will be asked to 
provide survey identification which includes numerical format of the birthday month 
and date.  Therefore, your responses will be confidential.  Only the project lead and 
the medical director of the clinic will have access to the completed survey 
questionnaire and written feedback will be used to make changes to the project as 
needed.  The result of the survey questionnaires will be presented to the project chair, 
committee members and other students or members who attend the project lead’s final 
defense at the University of Northern Colorado.  All the original survey questionnaires 
will be stored in a confidential folder inside the office of the medical director of the 
clinic and will be destroyed at the end of the project implementation.  
 
Risks to you are minimal.  You should not feel anxious or frustrated taking the survey 
questionnaires since the survey questionnaires are straight forward and easy to 
understand.  The benefits to you include increased awareness and knowledge on 
melanoma, melanoma screening, and interventions to prevent melanoma.   
 
Participation is voluntary.  You may decide not to participate in this study and if you 
begin participation you may still decide to stop and withdraw at any time. Your 
decision will be respected and will not result in loss of benefits to which you are 
otherwise entitled. Please take your time to read and thoroughly review this document 
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and decide whether you would like to participate in this research study.  If you decide 
to participate, your completion of the research procedures indicates your consent.  
Please keep or print this form for your records. If you have any concerns about your 
selection or treatment as a research participant, please contact Nicole Morse, Office 
of Research, Kepner Hall, University of Northern Colorado Greeley, CO  80639; 970-
351-1910. 
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Individual Investigator Agreement 
 
 
Name of Institution with the Federalwide Assurance (FWA): University of 
Northern Colorado   
 
Applicable FWA #: FWA00000784 
 
Individual Investigator’s Name: 
____________________________________________________ 
 
Specify Research Covered by this Agreement:  Screening for Melanoma for At-risk 
Population: A practice guide 
 
UNC PIs: Sapana Shakya and Advisor, Dr. Melissa Henry 
 
 
(1) The above-named Individual Investigator has reviewed:  1) The Belmont Report: 
Ethical Principles and Guidelines for the Protection of Human Subjects of 
Research (or other internationally recognized equivalent; see section B.1. of the 
Terms of the Federalwide Assurance (FWA) for International (Non-U.S.) 
Institutions); 2) the U.S. Department of Health and Human Services (HHS) 
regulations for the protection of human subjects at 45 CFR part 46 (or other 
procedural standards; see section B.3. of the Terms of the FWA for International 
(Non-U.S.) Institutions); 3) the FWA and applicable Terms of the FWA for the 
institution referenced above; and 4) the relevant institutional policies and 
procedures for the protection of human subjects. 
 
(2) The Investigator understands and hereby accepts the responsibility to comply with 
the standards and requirements stipulated in the above documents and to protect 
the rights and welfare of human subjects involved in research conducted under this 
Agreement. 
 
(3) The Investigator will comply with all other applicable federal, international, state, 
and local laws, regulations, and policies that may provide additional protection for 
human subjects participating in research conducted under this agreement. 
 
(4) The Investigator will abide by all determinations of the Institutional Review Board 
(IRB) designated under the above FWA and will accept the final authority and 
decisions of the IRB, including but not limited to directives to terminate 
participation in designated research activities. 
 
(5) The Investigator will complete any educational training required by the Institution 
and/or the IRB prior to initiating research covered under this Agreement. 
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(6) The Investigator will report promptly to the IRB any proposed changes in the 
research conducted under this Agreement.  The investigator will not initiate 
changes in the research without prior IRB review and approval, except where 
necessary to eliminate apparent immediate hazards to subjects. 
 
(7) The Investigator will report immediately to the IRB any unanticipated problems 
involving risks to subjects or others in research covered under this Agreement. 
 
(8) The Investigator, when responsible for enrolling subjects, will obtain, document, 
and maintain records of informed consent for each such subject or each subject’s 
legally authorized representative as required under HHS regulations at 45 CFR 
part 46 (or any other international or national procedural standards selected on the 
FWA for the institution referenced above) and stipulated by the IRB/IEC. 
 
(9) The Investigator acknowledges and agrees to cooperate in the IRB’s responsibility 
for initial and continuing review, record keeping, reporting, and certification for 
the research referenced above.  The Investigator will provide all information 
requested by the IRB in a timely fashion. 
 
(10) The Investigator will not enroll subjects in research under this Agreement prior to 
its review and approval by the IRB. 
 
(11) Emergency medical care may be delivered without IRB review and approval to the 
extent permitted under applicable federal regulations and state law.   
 
(12) This Agreement does not preclude the Investigator from taking part in research not 
covered by this Agreement. 
 
(13) The Investigator acknowledges that he/she is primarily responsible for 
safeguarding the rights and welfare of each research subject, and that the subject’s 
rights and welfare must take precedence over the goals and requirements of the 
research. 
 
Investigator Signature: ____________________________ Date _______________ 
 
Name: _________________________________________ Degree(s): _____________ 
 (Last)           (First)            (Middle Initial) 
Address:  _____________________________________ phone #:  ________________ 
 
     ________________________________________________ 
 (City)        (State/Province)           (Zip/Country) 
 
FWA Institutional Official (or Designee): __________________ Date ___________ 
Dr. Mark Anderson, Provost 
 
Address:  501 20
th
 Street, Greeley, Colorado 80639; 970-351-2305 
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Please DONOT put any patient identifier (NO NAME/AGE/GENDER) on this paper 
 
Answer each question by checking the appropriate square.  
1. What type of skin do you have?  
o Skin-type I: Very fair skin, blond or red hair, light eyes (blue or green), 
never tan and always sunburn after sun exposure.  
o Skin-type II: Fair skin, blond or light brown hair, light eyes (blue or 
green), usually sunburn.  
o Skin-type III: Dark skin, brown hair, light to medium eye color.  
o Skin-type IV: Olive skin, dark brown hair, brown eyes. 
o Skin-type V: Brown skin, black hair, black eyes.  
o Skin-type VI: Black skin, black hair, black eyes.  
2. Do you have freckles?  
o Yes 
o No 
3. How many moles do you approximately have on both arms?  
o More than 20 
o Fewer than 20 
4. Have you had one or more episodes of severe blistering sunburn during 
childhood or teenage years? 
o Yes 
o No 
5. Did you live more than 1 year in a country where sunshine is high (Africa, 
French West Indies, South of United States, Australia)?  
o Yes 
o No 
6. Have you been diagnosed with melanoma in the past (It is a skin cancer, 
arising in melanocytes, skin cancer that make skin pigment? 
o Yes 
o No 
7. Has any of your first-degree relatives (parents, children, brother or sister) ever 
had melanoma?  
o Yes 
o No 
According to the SAMScore, a patient is considered at risk for melanoma if at least 
one of these 3 criteria is verified:  
First criterion: Presence of at least 3 risk factors among the 7 following risk 
factors: phototype I or II, freckling tendency, number of melanocytic nevi >20 on both 
arms, severe sunburn during childhood or teenage years, life in a country at low 
latitude, a history of previous melanoma, a history of melanoma in a first-degree 
relative.  
 
Second criterion: A subject under 60 years of age and a number of 
melanocytic nevi >20 on both arms 
 
Third criterion: A subject of 60 years old or over and a freckling tendency 
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RETROSPECTIVE CHART REVIEW DATA COLLECTION 
Number of Annual visits Number of Establish visits 
  
 
 
Melanoma Screening Total Number of Patients 
Yes  
No  
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INTERVENTION CHART REVIEW DATA COLLECTION 
Number of 
Annual visits 
Number of 
Establish visits 
Number of 
patients qualified 
for the project 
Number of 
patients not 
qualified for the 
project 
    
 
 
Patient 
Numbe
rs 
Ag
e 
Gende
r 
+SA
M 
-
SA
M 
IC
D 
10 
Keyword
s 
Intervention/Educati
on 
P1        
P2        
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PRE-SURVEY QUESTIONNAIRE (Providers) 
Providers: Please fill out the following questionnaire to assist the project lead in 
identifying current practice and provide barriers/feedbacks/suggestions for melanoma 
screening in primary care.  
 
1. Do you currently screen patients for melanoma or skin cancer during their 
annual wellness visits?  
o Yes 
o No 
 
2. What percentage approximates the number of patients you currently screen?  
o 100%  
o 75%  
o 50%  
o 25% 
o 0% 
 
3. Have you heard or learned about SAMScore for melanoma screening? 
o Yes 
o No 
 
4. If answered Yes to question 2, where did you hear or learn about SAMScore? 
If answered No to question 2, Go to question 7. 
 
 
 
5. How many risk factors on the SAMScore are needed for the patient to be 
considered at risk for melanoma? 
o 1 
o 2 
o 3 
o 4 
 
6. Please check the appropriate boxes for the positive SAMScore 
o At least 3 of the 7 risk factors 
o Older than 60 with more than 20 nevi on both arms and freckles 
o Younger than 60 with more than 20 nevi on both arms 
o Older than 60 with freckling tendency 
 
7. The ICD 10 code and key words in plan section of the SOAP note will be used 
by the project lead to evaluate the objectives.  
o True  
o False 
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8. Have you heard or learned about melanoma early detection provider toolkit 
through OSHU or any toolkit for melanoma screening?  
o Yes 
o No 
 
9. Would you intend to use melanoma early detection provider toolkit as a 
resource for melanoma screening?  
o Yes 
o No 
 
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:  
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POST-SURVEY QUESTIONNAIRE (Providers) 
Providers: Please fill out the following questionnaire to assist the project lead in 
identifying your intention, understanding of the algorithm and SAMScore and provide 
barriers/feedbacks/suggestions for melanoma screening in primary care.  
 
1. After participating in the melanoma screening “lunch and learn session”, do 
you intend to change your current screening practice for melanoma or skin 
cancer by incorporating SAMScore or evidence-based melanoma algorithm to 
a greater number of patients during 
annual wellness visits?  
a. Yes 
b. No 
 
2. How many risk factors on the SAMScore are needed for the patient to be 
considered at risk for melanoma? 
a. 1 
b. 2 
c. 3 
d. 4 
 
3. Please check the appropriate boxes for the positive SAMScore 
a. At least 3 of the 7 risk factors 
b. Older than 60 with more than 20 nevi on both arms and freckles 
c. Younger than 60 with more than 20 nevi on both arms 
d. Older than 60 with freckling tendency 
 
4. The ICD 10 code and key words in plan section of the SOAP note will be used 
by the project lead to evaluate the objectives.  
o True  
o False 
 
5. Do you intend to use melanoma early detection provider toolkit as a resource 
for melanoma screening?  
a. Yes 
b. No 
 
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:  
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POST-POST SURVEY QUESTIONNAIRE (Providers) 
Providers: Please fill out the following questionnaire to assist the project lead in 
identifying providers intention to utilize the algorithm and resources.   
 
1. Do you intend to continue to screen patients for melanoma or skin cancer 
during their annual wellness visits?  
c. Yes 
d. No 
 
 
2. Do you intend to use the melanoma screening algorithm developed for this 
practice or different melanoma early detection provider toolkit as a resource 
for melanoma screening in the future?  
a. Yes 
b. No 
 
Barriers/Feedbacks/Suggestions to melanoma screening in primary care you 
encountered during the melanoma screening pilot project: 
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PRE-SURVEY QUESTIONNAIRE (Medical assistants) 
Medical assistants: Please fill out the following questionnaire to assist the project lead 
in identifying your understanding of project lead’s melanoma screening algorithm and 
SAMScore and provide barriers/feedbacks/suggestions to improve melanoma 
screening in primary care.  
 
1. Have you heard or learned about SAMScore for melanoma screening? 
o Yes 
o No 
 
2. If answered Yes to question 1, where did you hear or learn about SAMScore?  
 
 
3. The inclusion criteria for the patients to have the SAMScore includes.  
o Patients younger than 35 and older than 75 for acute visits 
o Patients aged 35-75 presenting for their annual physical 
o Able to read, write and speak English 
o English and Spanish speakers 
 
4. The exclusion criteria for the patients to not have the SAMScore includes. 
o Patients younger than 35 and older than 75 for acute visits 
o Patients aged 35-75 presenting for their annual physical 
o Able to read, write and speak English 
o English and Spanish speakers 
o Well women visits 
 
5. Medical assistants will make a copy of the Original SAMScore filled out by 
patients, copied SAMScore will be scanned into the electronic health record 
and the original will be stored securely in a folder for the project lead to 
collect.  
o True  
o False 
 
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:  
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POST-SURVEY QUESTIONNAIRE (Medical assistants) 
Medical assistants: Please fill out the following questionnaire to assist the project lead 
in identifying your understanding of project lead’s melanoma screening algorithm and 
SAMScore and provide barriers/feedbacks/suggestions to improve melanoma 
screening in primary care.  
 
1. The inclusion criteria for the patients to have the SAMScore includes.  
o Patients younger than 35 and older than 75 for acute visits 
o Patients aged 35-75 presenting for their annual physical 
o Able to read, write and speak English 
o English and Spanish speakers 
 
2. The exclusion criteria for the patients to not have the SAMScore includes. 
o Patients younger than 35 and older than 75 for acute visits 
o Patients aged 35-75 presenting for their annual physical 
o Able to read, write and speak English 
o English and Spanish speakers 
o Well women visits 
 
3. Medical assistants will make a copy of the Original SAMScore filled out by 
patients, copied SAMScore will be scanned into the electronic health record 
and the original will be stored securely in a folder for the project lead to 
collect.  
o True  
o False 
 
Barriers/Feedbacks/Suggestions to melanoma screening in primary care:  
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APPENDIX R 
HANDOUT FROM AMERICAN ASSOCIATION 
OF DERMATOLOGY 
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APPENDIX S 
PERMISSION E-MAIL FROM AMERICAN 
ASSOCIATION OF DERMATOLOGY 
TO USE HANDOUT 
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APPENDIX T 
 
MELANOMA SCREENING WORKFLOW 
ALGORITHM FOR PROVIDERS 
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Melanoma screening workflow algorithm for at-risk population in primary care 
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APPENDIX U 
MELANOMA SCREENING WORKFLOW 
ALGORITHM FOR MEDICAL 
ASSISTANTS 
 
163 
 
Melanoma screening workflow algorithm for Medical Assistant at the clinic 
 
